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Summary 
 
The endoplasmic reticulum (ER) and mitochondria accumulate Ca
2+
 within their lumens to 
regulate numerous cell functions. However, determining the dynamics of intraorganellar Ca
2+
 
has proven to be difficult. Here, I describe a family of genetically-encoded Ca
2+
 indicators, 
named calcium-measuring organelle-entrapped protein indicators (CEPIA), which can be 
utilized for intra-organellar Ca
2+
 imaging. CEPIA, which emit green, red or blue/green 
fluorescence, are engineered to bind Ca
2+
 at intra-organellar Ca
2+
 concentrations. They can be 
targeted to different organelles and may be used alongside other fluorescent molecular 
markers, expanding the range of cell functions that can be simultaneously analyzed. The 
spatiotemporal resolution of CEPIA makes it possible to resolve Ca
2+
 import into individual 
mitochondria while simultaneously measuring ER and cytosolic Ca
2+
. These imaging 
capabilities were used to reveal differential Ca
2+
 handling in individual mitochondria. CEPIA 
imaging is a useful new tool to further the understanding of organellar functions. 
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Introduction 
 
Ca
2+
 is an important second messenger that regulates numerous cellular functions including 
contraction, fertilization, proliferation and synaptic plasticity (1). The versatility of Ca
2+
 
signals principally relies on the capacity of various types of cells to control spatiotemporal 
distribution of cytosolic Ca
2+
 levels to fit their physiology (2). In the resting state, Ca
2+
 
concentration in the cytosol is kept below 100 nM, which is three to four orders of magnitude 
lower than that in the extracellular space or intracellular Ca
2+
 stores. In response to 
Ca
2+
-mobilizing stimulation, the cytosolic Ca
2+
 concentration rises up to 1000 nM or higher 
and may fluctuate in a time dependent manner. Cytosolic Ca
2+
 signals are generated by two 
distinct pathways; Ca
2+
 influx from the extracellular space and Ca
2+
 release from the 
intracellular Ca
2+
 store, and there is a complex crosstalk between these two pathways. 
Furthermore, in response to cytosolic Ca
2+
 signaling, Ca
2+
 concentrations in the intracellular 
organelles such as mitochondria and nuclei also increase (3,4). To understand these complex 
signaling processes, optical Ca
2+
 imaging using Ca
2+
 indicators, which alter their spectral 
properties depending on their surrounding Ca
2+
 concentration, is a powerful and useful 
method. Indeed, optical Ca
2+
 imaging techniques have been successfully used to decipher 
spatiotemporal dynamics and physiological functions of cytosolic Ca
2+
 signals in cells in 
culture, in ex vivo samples and in living animals (5). In contrast to the success of cytosolic 
Ca
2+
 imaging techniques, there are several limitations in the existing methods available for 
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monitoring Ca
2+
 dynamics in the organelles such as the endoplasmic reticulum (ER) and 
mitochondria.  
The ER and mitochondria are membrane-bound intracellular organelles in eukaryotic 
cells that carry out vital functions. Both ER and mitochondrial membranes display 
Ca
2+
-transporting molecules whose function is to import Ca
2+
 into the lumen against the 
concentration gradient. This uphill Ca
2+
 transport is mediated in the ER membrane by 
sarco(endo)plasmic reticulum Ca
2+
 ATPase (SERCA) (6) and in the inner mitochondrial 
membrane by the mitochondrial Ca
2+
 uniporter (MCU) (3). The organellar membranes also 
feature molecules that allow Ca
2+
 to exit from the organelles to the cytosol: inositol 
1,4,5-trisphosphate receptor (IP3R) and ryanodine receptor (RyR) in the ER, and the Na
+
/Ca
2+
 
and H
+
/Ca
2+
 exchanger in mitochondria (3,7). Thus, the intraluminal Ca
2+
 concentration in the 
organelles is tightly regulated, and may exceed that of cytosol by a large factor. Ca
2+
 levels 
within the ER profoundly affect organelle functions, and overload or depletion causes ER 
stress (8). Within the mitochondrial matrix, Ca
2+
 concentration regulates the rate of ATP 
production, and abnormal concentrations can lead to cell death or autophagic degradation of 
the mitochondria (3). 
ER and mitochondrial structures are constantly being reorganized and close contacts 
form between the two types of organelles. These contact sites have recently been shown to be 
involved in diverse functions, including lipid biosynthesis, mitochondrial biogenesis and the 
transfer of Ca
2+
 (9-12). Both types of organelle are also involved in the regulation of cytosolic 
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Ca
2+
 concentration. Release of Ca
2+
 from the ER regulates contraction, fertilization, 
development, secretion, and synaptic plasticity (7). In addition, the ER luminal Ca
2+
 
concentration regulates Ca
2+
 influx across the plasma membrane. Following a release of Ca
2+
 
from the ER, stromal interaction molecule 1 (STIM1), which is present in the ER membrane, 
functions as a Ca
2+
 transducer; it signals to the plasma membrane to activate the 
store-operated Ca
2+
 entry mechanism (SOCE) (13,14). SOCE is mediated by the molecular 
complex that includes Orai1, a Ca
2+
 channel on the plasma membrane, and is important for 
the activation of various cell functions, the best-studied example of which is the immune 
responses (13). In contrast to the active role of the ER in Ca
2+
 signaling, mitochondria have 
been considered to act as a passive Ca
2+
 buffer (3). However, recent results suggest that they 
may also have an active role as a source of Ca
2+
 in the regulation of cytosolic Ca
2+
 
concentration (15). 
Although the importance of the ER and mitochondria as Ca
2+
-handling organelles is 
unequivocal, the mechanism by which organellar Ca
2+
 concentrations regulate cellular 
processes remains elusive. New methods to dissect organellar Ca
2+
 dynamics are expected to 
facilitate such studies. While small molecular Ca
2+
 indicators cannot be precisely targeted to 
the organelles, limiting their use in living cells, genetically-encoded Ca
2+
 indicators (GECIs) 
can be targeted to organelles with the addition of appropriate tags (16). Making use of this 
capability, GFP-based GECIs (10,11,15,17-48) and aequorin (a Ca
2+
-sensitive photoprotein) 
(49) have been used to measure intraorganellar Ca
2+
 concentrations. FRET-type GFP-based 
 7 
GECIs were first used to measure intraluminal Ca
2+
 concentration in the ER and were applied 
to different cell types (15,17,22,23,25-28,30-32,36,47,48). This type of indicators uses wide 
visible wavelength bands for excitation and emission, often limiting the simultaneous use of 
other fluorescent molecules (50,51). Subsequently, innovative modifications of the GFP 
molecule have yielded single-wavelength-excitation GECIs with various affinities to Ca
2+
 for 
ER and mitochondrial Ca
2+
 imaging (18-21,24,33-35,39,41,42,45,46). Aequorin emits dim 
light, and simultaneous measurement with brighter fluorescence signals is not possible with 
most fluorescence microscopes. Although there are a wide variety of indicators, simultaneous 
Ca
2+
 imaging of the ER and mitochondria has not been carried out, and improvement in the 
spatiotemporal resolution of organellar Ca
2+
 is expected to enhance our understanding of 
intraorganellar Ca
2+
 dynamics. For these reasons, and to study the functional interaction 
between the ER and mitochondria, a new type of GECIs with higher spatiotemporal 
resolution was required. 
This study reports on the generation of new organellar Ca
2+
 indicators that allow 
simultaneous imaging of two subcellular compartments with high spatiotemporal resolution. 
They are optimized in terms of Ca
2+
 affinity and dynamic range for organellar Ca
2+
 imaging 
and come in color variants for simultaneous measurement of multiple signals when they are 
used in appropriate combinations. Using them, intraorganellar Ca
2+
 concentrations can be 
imaged at unprecedented spatiotemporal resolution. To illustrate the utility of the approach, I 
demonstrate high spatiotemporal resolution imaging of ER and mitochondrial Ca
2+
 dynamics 
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in living cells; I show the quantitative relationship between the ER Ca
2+
 concentration and the 
extent of STIM1 puncta formation in the regulation of SOCE; and I show that inhomogeneity 
in mitochondrial Ca
2+
 responses can be observed during apparently homogenous ER and 
cytosolic Ca
2+
 changes, which suggests that there is a mechanism to regulate the influx of 
Ca
2+
 into mitochondria. The new indicators described in this work will be valuable for further 
study of the roles of the ER and mitochondria, and of their functional interactions. 
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Materials and Methods 
 
Gene construction 
For creating a CEPIA library, cfGCaMP2 (GCaMP2 with amino acid substitutions of M36L in 
CaM, and N105Y and E124V in circular permutated enhanced GFP (cpEGFP)) with ER 
retention signal sequence (SEKDEL) was cloned into a bacterial expression vector, pET19b 
(Novagen, USA), using primers 1 and 2 (Table 3). G-GECO1.1, R-GECO1 and 
GEM-GECO1 were also cloned into pET19b using primers 3 and 4. The CaM sequences in 
cfGCaMP2 variants were replaced with those in G-GECO1.1, R-GECO1 or GEM-GECO1 
using primers 4–7. Site-directed mutagenesis was performed by PCR using primers 8–36. 
 For mammalian expression of CEPIA variants in the ER and mitochondria, CEPIA 
variants were cloned into pCMV/myc/ER and pCMV/myc/mito vector (Invitrogen, USA) 
using primers 3, 4 and 37–39. For mitochondrial Ca2+ imaging, the specificity of 
mitochondrial localization was enhanced by attaching the mitochondria targeting sequences in 
tandem (29) to CEPIA2–4mt, R-GECO1mt and GEM-GECO1mt using primers 40–47. To 
enhance protein expression, GEM-CEPIA1er was cloned into the CAG promoter-containing 
vector, pCIS, using primers 48 and 49. To express G-CEPIA1er in the Purkinje cells, 
G-CEPIA1er was cloned into pSinRep5 (Invitrogen) using primers 50–53. To localize EGFP 
and mCherry in the ER, EGFP and mCherry were cloned into the pcDNA3 D1ER (23) to 
attach calreticulin signal sequence and ER retention signal (KDEL) using primers 54–59. To 
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construct EYFP-er, EYFP was cloned from pcDNA3-YC4er (17) into pCMV/myc/ER vector 
using primers 60 and 61. To construct SypHer-dmito, an amino acid substitution of C199S 
(52) was added in pHyper-dmito (Evrogen, Russia) using primers 62 and 63. To construct 
mCherry-STIM1, STIM1 was cloned from pApuro-GFP-STIM1 (53) into pShuttle2 vector 
using primers 60 and 64–66. 
 
Bacterial expression and in vitro spectroscopy 
BL21-CodonPlus(DE3)-RIL bacteria (Stratagene, USA) was transformed with the plasmids 
and incubated for 16–36 h at 37°C in 2×YT medium containing ampicillin and 
chloramphenicol (20 μg ml–1). The cells were resuspended in KCl/MOPS buffer (130 mM 
KCl, 50 mM MOPS, pH 7.2). After cell lysis with sonication, recombinant proteins were 
purified using TALON metal affinity resin (Clontech, USA) and dialyzed with Slide-A-Lyzer 
Dialysis Cassettes, 10K MWCO (Thermo Fisher Scientific, USA). 
 Ca
2+
 and Mg
2+
 titration curves of CEPIA variants were obtained by adding small 
aliquots of CaCl2 or MgCl2 to the recombinant indicators in a KCl/MOPS buffer containing 0 
or 1 mM EGTA at pH 7.2. The Ca
2+
 concentration carried over from the recombinant protein 
samples was estimated as 2 µM. In the presence of 1 mM EGTA, the [Ca
2+
]free at pH 7.2 was 
calculated as follows: 
[Ca
2+
]free = [D + (4 × Kd × [Ca
2+
]total + D
2
)
1/2
] / 2, 
D = [Ca
2+
]total – [EGTA]total – Kd, 
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Kd = [EGTA]free × [Ca
2+
]free / [CaEGTA] = 150.5 nM, 
where Kd is the dissociation constant of CaEGTA (54). To estimate properties of CEPIA 
variants in mitochondria, titration experiments were performed in a KCl/HEPES buffer at pH 
8.0 to mimic the mitochondrial environment (55), containing 1 mM BAPTA assuming a Kd of 
0.1 µM. Fluorescence intensity was measured with a spectrofluorometer (FP-750, Jasco, 
Japan) for each protein at excitation/emission wavelength; 488/512 nm for cfGCaMP2 and 
G-GECO1.1 variants, 562/584 nm for R-GECO1 variants, and 395/460 nm and 395/510 nm 
for GEM-GECO1 variants. The obtained Ca
2+
-fluorescence intensity relationships were fitted 
by the following Hill equations using a least-square method in the Kaleidagraph software 
(Synergy Software, USA). For cfGCaMP2, G-GECO1.1 and R-GECO1 variants, 
F = Fmin + (Fmax – Fmin) × ([Ca
2+
]free)
n
 / [([Ca
2+
]free)
n
 + (Kd)
n
]. 
For GEM-GECO1 variants, 
R = Rmin + (Rmax – Rmin) × ([Ca
2+
]free)
n
 / [([Ca
2+
]free)
n
 + (Kd)
n
], 
where R = (F at 460 nm) / (F at 510 nm). Kd represents an apparent dissociation constant, or 
the Ca
2+
 concentration at which half of the indicator molecules bind to Ca
2+
. n represents Hill 
coefficient. The dynamic range of the indicator was calculated as the ratio of maximum and 
minimum fluorescence intensity or ratio (Fmax/Fmin or Rmax/Rmin). Fluorescence intensity at 
various Ca
2+
 concentrations was standardized by the following equation: 
θ = (F – Fmin) / (Fmax – Fmin) or (R – Rmin) / (Rmax – Rmin). 
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The absorbance spectra were measured with a spectrophotometer (DU-640 UV/VIS, 
Beckman, USA). To determine the molar extinction coefficient (ε), absorbance spectrum was 
measured first for each protein in KCl/MOPS buffer with or without 5 mM CaCl2. The 
extinction coefficient was calculated by dividing the peak absorbance by protein 
concentration. The protein concentrations for G-CEPIA1er, GEM-CEPIA1er, G-GECO1.1 
and GEM-GECO1 were calculated by measuring the absorbance following alkaline 
denaturation, assuming ε = 44,000 M–1 cm–1 at 446 nm. For R-CEPIA1er and R-GECO1, ε = 
38,000 M
–1
 cm
–1
 at 455 nm (24). Quantum yields (Φ) of CEPIAer were calculated by using 
G-GECO1.1, R-GECO1 and GEM-GECO1 as standards (24). 
 
Animal experiments 
All animal experiments were carried out in accordance with the regulations and guidelines for 
Institutional Animal Care and Use Committee at the University of Tokyo and were approved 
by the institutional review committees of the Graduate School of Medicine, the University of 
Tokyo. 
 
Cell culture 
HeLa cells, HEK293A cells, BHK cells and astrocytes were cultured on collagen-coated 
dishes in DMEM supplemented with 10% fetal bovine serum, penicillin (100 U ml
–1
) and 
streptomycin (100 U ml
–1
). Jurkat T cells (E6-1) were maintained in RPMI medium (Gibco, 
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USA) supplemented with 10% fetal bovine serum. An astrocytic culture with >95% purity 
was prepared by several replatings of the brain cell culture which was obtained by 2.5% 
trypsin treatment and gentle trituration of the neocortices or the hippocampi of embryonic day 
18–19 or postnatal day 1–3 Sprague–Dawley rat fetuses (56). For Ca2+ imaging, the cells were 
plated on collagen type-I-coated glass-bottom dishes (MatTek, USA) or Cell-Tak-coated 
dishes (Corning, USA) before imaging. 
 
Time-lapse Ca
2+
 imaging 
Cultured cells were transfected using Lipofectamine 2000 (Invitrogen) two or three days 
before imaging. Jurkat T cells were electroporated using a MicroPorator (MP-100, Digital Bio, 
Korea) one day before imaging. For cytosolic Ca
2+
 imaging using fura-2, cells were loaded 
with 5 μM fura-2 AM (Molecular Probes, USA) at room temperature (RT; 22–24°C) for 
40–60 min in 0.1% BSA-supplemented physiological salt solution (PSS) containing (in mM) 
150 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 5.6 glucose, and 25 HEPES (pH 7.4). Prior to imaging, 
the loading solution was replaced with PSS without BSA. The images were captured using an 
inverted microscope (IX81, Olympus, Japan) equipped with a 20× objective (numerical 
aperture (NA) = 0.75, UPlanSApo, Olympus) or a 40× objective (NA 0.90, UApo/340, 
Olympus), an electron multiplying cooled-coupled device (EM-CCD) camera (ImagEM, 
Hamamatsu photonics, Japan), a filter wheel (Lambda 10-3, Sutter Instrument, USA), a xenon 
lamp (ebx75) and a metal halide lamp (EL6000, Leica, Germany) at a rate of one frame per 2 
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or 3 s with the following excitation/emission filter settings: 472 ± 15 nm/520 ± 17.5 nm for 
CEPIA1er, G-CEPIA1er, CEPIA2–4mt, EYFP-er and G-GECO1.1, ; 562 ± 20 nm/641 ± 37.5 
nm for R-CEPIA1er, R-GECO1 and mCherry-STIM1; 377 ± 25 nm/466 ± 20 nm and 377 ± 
25 nm/520 ± 17.5 nm for GEM-CEPIA1er and GEM-GECO1; 340 ± 13 nm/510 ± 42 nm and 
365 ± 6 nm/510 ± 42 nm for fura-2; 440 ± 10.5 nm/480 ± 15 nm and 440 ± 10.5 nm/535 ± 13 
nm for D1ER (23,24). For analysis of the ratiometric indicators, the fluorescence ratio 
(F466/F520 for GEM-GECO1 and GEM-CEPIA1er; F340/F365 for fura-2; F535/F480 for D1ER) 
was calculated. Photobleaching was corrected for using a linear fit to the fluorescence 
intensity change before agonist stimulation. All images were analyzed with ImageJ software. 
To image subcellular ER Ca
2+
 dynamics during agonist-induced Ca
2+
 wave formation, 
HeLa cells expressing either G-CEPIA1er or R-CEPIA1er were used. Images were captured 
at a rate of one frame per 30–100 ms using a 60× objective (NA 1.45, PlanApo TIRF, 
Olympus) and the metal halide lamp or an LED lamp (pE-100, CoolLED, UK). To evaluate 
Ca
2+
 wave velocity in the ER and cytosol, images were normalized by the resting intensity, 
and a linear region of interest (ROI) was defined along the direction of wave propagation. A 
line-scan image was created by averaging 30 adjacent linear ROIs parallel to the original ROI, 
and time derivative was obtained to detect the time point which showed maximal change 
during the scan duration. Then the time points were plotted against the pixel, and the wave 
velocity was estimated by the slope of the least-squares regression line. 
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For mitochondrial Ca
2+
 imaging with ER and cytosolic Ca
2+
, mitochondrial inner 
membrane potential or mitochondrial pH at subcellular resolution, HeLa cells were imaged 
with a confocal microscope (TCS SP8, Leica) equipped with a 63× objective (NA 1.40, HC 
PL APO, Leica) at a rate of one frame per 2 or 3 s with the following excitation/emission 
spectra: R-GECO1mt (552 nm/560– nm), G-CEPIA1er (488 nm/500–550 nm) and 
GEM-GECO1 (405 nm/500–550 nm); GEM-GECO1mt (405 nm/500–550 nm) and JC-1 (488 
nm/500–550 nm and 488 nm/560– nm); R-GECO1mt (552 nm/560– nm) and SypHer-dmito 
(405 nm/500–550 nm and 488 nm/500–550 nm). For analysis of JC-1 and SypHer-dmito, the 
fluorescence ratio (488 nm/560– nm over 488 nm/500–550 nm for JC-1 (57); 488 
nm/500–550 nm over 405 nm/500–550 nm for SypHer-dmito (52)) was calculated. 
To perform in situ Ca
2+
 titration of CEPIA, the plasma membrane of HeLa cells was 
permeabilized with 150 μM β-escin (Nacalai Tesque, Japan) in a solution containing (in mM) 
140 KCl, 10 NaCl, 1 MgCl2 and 20 HEPES (pH 7.2). After 4 min treatment with β-escin, 
various Ca
2+
 concentrations were applied in the presence of 3 μM ionomycin and 3 µM 
thapsigargin, and estimated the maximum and minimum fluorescent intensity (Rmax and Rmin), 
dynamic range (Rmax / Rmin), Kd and n. 
For the estimation of [Ca
2+
]ER based on the ratiometric measurement using 
GEM-CEPIA1er (Figures 7c, 7d, 12f and 16), [Ca
2+
]ER was obtained by the following 
equation: 
[Ca
2+
]free = [(R – Rmin) / (Rmax – R)]
1/n
  Kd, 
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where R = (F at 466 nm)/(F at 510 nm), n = 1.37 and Kd = 558 μM. 
To evaluate pH dynamics in the ER (Figures 9a–d), HeLa cells expressing EYFP-er 
were first stimulated with histamine. Subsequently the cells were stimulated in a PSS 
(adjusted to pH 6.8) containing monensin (10 μM, Wako, Japan) and nigericin (10 μM, Wako). 
Then, the cells were alkalinized with a solution containing (in mM) 120 NaCl, 30 NH4Cl, 4 
KCl, 2 CaCl2, 1 MgCl2, 5 HEPES and 5.6 Glucose (pH 7.4) (58). 
 
Analysis of STIM1 dynamics 
STIM1 dynamics were analyzed using the ImageJ software. To extract STIM1 puncta, the 
captured images were binarized after filtering (Gaussian Blur or Unsharp Mask). Then, 
particles greater than 2 pixels (corresponding to ~1.2 µm
2) were counted using the “Analyze 
Particles” tool in the ImageJ. The counts were normalized by the maximum values (Npuncta) 
and plotted against the ER Ca
2+
 levels (ERCa
2+
) ([Ca
2+
]ER for GEM-CEPIA1er and F/F0 for 
G-CEPIA1er). Curve fitting was performed using the following Hill equation: 
Npuncta = 1 – (ERCa
2+
)
n
 / [(ERCa
2+
)
n
 + (K1/2)
n
], 
where K1/2 indicates the ER Ca
2+
 level at half maximal puncta formation and n represents Hill 
coefficient (59). 
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Imaging of subcellular localization of CEPIA 
All images were captured with a confocal microscope (TCS SP8) equipped with a 63× 
objective at the following excitation/emission wavelengths: CEPIA1er, G-CEPIA1er, 
CEPIA2mt, EGFP-er and EYFP-er (488 nm/500–550 nm), R-CEPIA1er, mCherry-er and 
MitoTracker Red (Invitrogen) (552 nm/560– nm) and GEM-CEPIA1er (405 nm/420–550 nm). 
The obtained images were merged with ImageJ software. 
 
ER Ca
2+
 imaging in cerebellar slices 
For Purkinje cell-specific expression of G-CEPIA1er, a Sindbis virus vector (pSinRep5) 
encoding G-CEPIA1er was produced. The pSinRep5-G-CEPIA1er vector was then used as 
the template for in vitro transcription using SP6 RNA polymerase (Ambion, USA). The RNA 
transcript and the helper RNA from DH(26S) cDNA template (Invitrogen) were cotransfected 
into BHK cells by electroporation. Twenty-four hours after transfection, the culture medium 
containing the infectious particles was harvested. Sindbis virus vector encoding EYFP-er was 
also produced with the same procedure. C57BL/6 mice (postnatal day 21–27) were deeply 
anesthetized
 
with pentobarbital, and the surface of cerebellar lobule 6 beside the midline was 
exposed by removing the cranium and dura. The tip of a glass pipette was backfilled with the 
viral solution. The glass pipette was then inserted
 
into the cerebellum and 1 µL of viral 
solution was delivered at a rate of 200 nl min
–1
 using a micropump (Legato 130, KD scientific, 
USA). Twenty-four hours after virus injection, parasagittal cerebellar slices (250 µm 
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thickness) were prepared (60). Mice were anesthetized with diethyl ether and decapitated. The 
brain was removed and placed in ice-cold artificial cerebrospinal fluid (ACSF). Slices were 
cut using a microslicer (PRO 7, Dosaka EM, Japan). The slices were incubated in a holding 
chamber containing ACSF at 35°C for 1 h and then returned to 23°C. Slices were transferred 
to a recording chamber under microscope and continuously perfused with ACSF 
supplemented with 10 µM bicuculline (Tocris Bioscience, UK) and 10 µM NBQX (Tocris 
Bioscience) to block inhibitory postsynaptic potentials and accompanying Ca
2+
 influxes. 
ACSF contained (in mM) 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, 
and 20 glucose, and was bubbled with 95% O2 and 5% CO2.  
Imaging was carried out with a two-photon microscope (TSC MP5, Leica) equipped 
with a water-immersion objective (25, NA 0.95, HCS IR APO, Leica) and a Ti:sapphire laser 
(MaiTai DeepSee; Spectra Physics, USA). Excitation wavelength was 900–920 nm for both 
G-CEPIA1er and EYFP-er. Data were acquired with time-lapse XY-scan mode (8 Hz) and 
analyzed using ImageJ software. Fluorescence intensities were corrected for background 
fluorescence by measuring a non-fluorescent area. When necessary, photobleaching was 
corrected for using a linear fit to the fluorescence intensity change. For the focal stimulation 
of parallel fibers, square pulses (0.1 ms) were applied through stimulation pipettes (3–6 µm 
tip diameter) filled with ACSF. The stimulation intensity was adjusted within 4–5 V to induce 
G-CEPIA1er signals with a range of ~20 µm in diameter. For EYFP-er, the stimulation 
intensity was fixed at 5V. Experiments were carried out at RT. 
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Statistics 
Two-tailed Student’s t-tests were performed to determine the significance if not stated 
otherwise. 
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Results 
 
Development of ER Ca
2+
 indicator 
I began measuring ER Ca
2+
 dynamics based on a lead variant of GCaMP2 (cfGCaMP2, see 
Materials and Methods), whereby fluorescence intensity increased 5.1-fold upon binding of 
Ca
2+
 with an apparent dissociation constant (Kd) of 0.67 µM (Table 1a). Since ER Ca
2+
 
concentration ([Ca
2+
]ER) is assumed to reach the sub-millimolar range, cfGCaMP2 was 
engineered to reduce its Ca
2+
 binding affinity by a factor of ~1,000. I searched for low Ca
2+
 
affinity variants guided by extensive structure-function analyses based on site-directed 
mutagenesis in the calmodulin (CaM) domain of cfGCaMP2.  
 Ca
2+
 affinity of cfGCaMP2 is primarily determined by CaM, which has four EF-hand 
motifs. I first tried the amino acid substitutions that were used to reduce Ca
2+
 affinity of the 
FRET-type ER Ca
2+
 indicator, D1ER (23), but the Kd of cfGCaMP2 increased only to 14.5 
µM (Figure 1a, gray circle). Amino acid substitutions at –Z position (12th amino acid residue) 
of the EF-hand motifs were previously shown to reduce the Ca
2+
 affinity of GFP-based Ca
2+
 
indicators (15,17). When a non-acidic substitution (E31Q) at –Z in site I was introduced to 
cfGCaMP2, the Kd increased to 64.9 µM. However, its dynamic range (Fmax/Fmin) was 
reduced to 2.5 (Figure 1a, green circle). Another non-acidic substitution (E104Q) at –Z in site 
III produced no effect on the Ca
2+
 affinity (Figure 1a, light green circle). On the other hand, 
conservative E31D substitution in site I increased the Kd to 14.5 µM without reducing the 
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dynamic range. Therefore, I next systematically altered the glutamate residue at –Z positions 
(E31, E67, E104, and E140) to aspartate. The E67D variant had a Kd of 9.2 µM, while E104D 
and E140D variants had Kds of 1.0 and 2.1 µM, respectively (Figure 1a, cyan circles). I then 
examined if combinations of multiple –Z substitutions would synergistically reduce the Ca2+ 
affinity. The Kd of E31D/E67D variant was strikingly increased to 470 µM, but its dynamic 
range was reduced to 2.6. Variants with other combinations of double substitutions had a Kd 
of ~25 µM, and retained a high dynamic range. Combinations of three –Z substitutions, 
(E31D or E67D)/E104D/E140D, produced variants with a Kd of some 130 µM (Figure 1a, 
blue circles). Thus I concluded that a different strategy for further improvement of the 
indicator was required. 
Previous reports have shown that a combination of F92W/D133E substitutions can 
inhibit Ca
2+
 binding at site IV of CaM (61,62). Based on these reports, I found that a 
cfGCaMP2 variant with F92W/D133E substitutions had a Kd of 10.3 µM and a high dynamic 
range (Figure 1a, orange circles). I next examined whether combinations of F92W/D133E and 
–Z substitutions would synergistically reduce Ca2+ affinity. Indeed, combinations of 
F92W/D133E and one of the –Z substitutions generated variants with a Kd of 67–130 µM 
(Figure 1a, magenta circles). I further combined the F92W/D133E substitutions with double 
–Z substitutions, (E31D or E67D) plus (E104D or E140D), and obtained variants with a Kd of 
~400 µM (Figure 1a, magenta circles). From among the 58 variants that were generated in 
this search, I finally selected one with E31D/F92W/E104D/D133E substitutions that had a 
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low Ca
2+
 affinity (Kd = 368 μM) and a large dynamic range (Fmax/Fmin = 4.2) (Table 1, Figures 
1a and 1b). After attaching ER localization and retention signal sequences (Figure 1c), the low 
Ca
2+
 affinity variant was expressed in HeLa cells. The engineered indicator protein 
co-localized with an ER marker (63) (Figure 1d). Upon addition of thapsigargin, an inhibitor 
of SERCA, a large reduction in fluorescence intensity was noted (Figure 1e). Also, oscillatory 
fluorescence intensity was observed in response to histamine, which generates cytosolic Ca
2+
 
oscillations due to release of Ca
2+
 from the ER via IP3Rs (Figure 1f). Thus, the indicator 
successfully reports [Ca
2+
]ER dynamics. I designated it Calcium-measuring 
organelle-Entrapped Protein IndicAtor 1 in the ER (CEPIA1er). 
 
Multi-coloring of CEPIA 
I next generated color variants of CEPIA, based on recently developed cytosolic Ca
2+
 
indicators: R-GECO1 (red fluorescence), G-GECO1.1 (green fluorescence) and 
GEM-GECO1 (ratiometric blue/green fluorescence) (24). I first replaced the entire CaM 
domain of R-GECO1 with that of CEPIA1er, and obtained a variant with a Kd of 70.9 µM 
(Table 1b). Introduction of an additional –Z substitution (E67D) resulted in a variant with an 
optimal Ca
2+
 affinity (Kd = 565 μM) and a high dynamic range (8.8) (Table 1b and Figure 2a), 
which I designated R-CEPIA1er. Using the same strategy, I replaced the CaM domain of 
G-GECO1.1 with that of CEPIA1er, and obtained a variant with a Kd of 672 µM and a 
dynamic range of 4.7. This variant was designated as G-CEPIA1er (Table 1c and Figure 2a). I 
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next tried the same strategy in GEM-GECO1, but found that the dynamic range of the 
resulting indicator was markedly reduced (Rmax/Rmin = 1.1; Table 1d). Because several amino 
acid substitutions had been introduced to the CaM of GEM-GECO1 as compared with 
cfGCaMP2 (Figure 3), I concluded that these additional substitutions are essential. 
Accordingly, I created a variant where I reintroduced the GEM-GECO1 substitutions while 
maintaining the E31D/F92W/E104D/D133E substitutions, creating a variant with a low Ca
2+
 
affinity and an increased dynamic range (Kd = 225 μM, Rmax/Rmin = 8.1; Table 1e). I further 
engineered the –Z positions, thus creating a variant with E31D/F92W/D133E/E140D 
substitutions with an optimal Ca
2+
 affinity and a high dynamic range (Kd = 558 μM, Rmax/Rmin 
= 21.7; Table 1e and Figure 2a). I designated this variant GEM-CEPIA1er. Substituted amino 
acids in each CEPIAer and genealogy of CEPIA variants were summarized in Figures 3 and 4, 
respectively. Spectral properties and in vitro characteristics of CEPIAer, compared with those 
of original GECO, were summarized in Table 2, Figures 5 and 6. 
I expressed the color variants of CEPIA fused with ER-targeting signal sequences in 
HeLa cells. They localized to the ER (63,64) (Figures 2b–d), and detected ER Ca2+ signals 
including agonist-induced Ca
2+
 oscillation with a high signal-to-noise ratio (Figures 7a and 
7b). In HeLa cells, G-CEPIA1er showed superior performance in signal amplitude over 
CEPIA1er (Figures 7a and 7b). To measure the Ca
2+
 affinity of CEPIA variants within the ER, 
I carried out Ca
2+
 titration experiments in permeabilized HeLa cells. Stepwise changes in Ca
2+
 
concentration elicited dose-dependent fluorescence intensity changes in the presence of 
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ionomycin to make the ER membrane permeable to Ca
2+
 (Figure 8a). The Kd values 
determined within the ER were almost equivalent to those measured in vitro (Figure 8b). To 
examine whether pH changes had any effect on the signal of CEPIA indicators (Figure 6a), I 
monitored pH dynamics in the ER using a pH sensor, enhanced yellow fluorescent protein 
(EYFP, pKa = 6.9) (65,66), because the pH value in the ER is estimated as 7.2 (55). There was 
no significant change in the fluorescence intensity of ER-localized EYFP (Figures 9a–d), 
verifying that the CEPIA responses are not due to pH changes in the ER. Thus, I succeeded in 
expanding the hues of CEPIA variants. 
 
Estimation of [Ca
2+
]ER 
Using ratiometric measurement with GEM-CEPIA1er, I estimated [Ca
2+
]ER in intact resting 
cells as varying between 620 and 860 µM in HeLa cells, HEK293A cells, BHK cells and 
cultured astrocytes; these decreased to 310–570 µM upon stimulation with agonists (Figure 
7d). The range of [Ca
2+
]ER underlines the need to increase the indicator’s Kd to >100 µM to 
provide faithful measurements of ER Ca
2+
 dynamics, and explains the difficulty in imaging 
ER Ca
2+
 dynamics using D1ER, which has a Kd of ~60 µM (23) (Figures 2a, 7a and 7b). 
Although CEPIA indicators had relatively high Hill coefficients (n = 1.4–2.0, Table 2), the 
relationship between F/Fmax (or R/Rmax) and changes in [Ca
2+
] is not highly distorted 
within the physiological [Ca
2+
]ER range (Figure 6c). 
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Subcellular ER Ca
2+
 dynamics visualized with CEPIA 
I next examined whether CEPIA indicators are capable of detecting ER Ca
2+
 dynamics at 
subcellular resolution. Agonists often induce Ca
2+
 waves, which propagate throughout the cell 
after initiation in focal regions (1,67). The wave is generated by the regenerative release of 
Ca
2+
 from the ER, and it has been predicted that this mechanism creates an “inverse Ca2+ 
wave” within the ER. However, this prediction has not been tested using GECIs in live cells. I 
used G-CEPIA1er imaging at a high frame rate (10–30 frames s–1) to visualize inverse Ca2+ 
waves in the ER. Local decreases in [Ca
2+
]ER were observed, initiating at the tips and 
propagating to the perinuclear region in HeLa cells (Figure 10a). The time courses measured 
at two subcellular locations indicated a wave-like propagation of decreasing [Ca
2+
]ER (Figures 
10b and 10c). The speed of these waves was 60.8 ± 3.2 μm s–1 (mean ± s.e.m.), which 
matches cytosolic Ca
2+
 waves with or without CEPIA expression (Figure 10d). Similar 
observations were made with R-CEPIA1er (Figure 10d). Thus, CEPIA indicators have high 
spatiotemporal resolution. 
Next, it was examined whether CEPIA can be applied to intact tissue preparations. To 
do so, Ca
2+
 dynamics were elucidated in the neuronal ER in response to synaptic inputs to 
Purkinje cell dendrites in cerebellar slice preparations. G-CEPIA1er was expressed in 
Purkinje cells by Sindbis virus and was imaged with a two-photon microscope. G-CEPIA1er 
expression was observed throughout the dendrites and into spines, matching the distribution 
of the ER in Purkinje cells (Figure 11a). In response to parallel fiber (PF) stimulation, which 
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induces Ca
2+
 release from the ER through IP3R by activating the metabotropic glutamate 
receptor 1 (mGluR1) (68), a long-lasting decrease in G-CEPIA1er fluorescence intensity was 
observed (Figure 11b). The ER Ca
2+
 dynamics could be visualized at the level of single spines 
(Figure 11c). This response was blocked by the application of LY367385, an mGluR1 
antagonist (Figures 11d and 11e, blue), but not by the application of NBQX, an AMPA 
receptor antagonist (Figures 11d and 11e, magenta). The application of CPA, a SERCA 
inhibitor, induced slow depletion of ER Ca
2+
 (Figure 11f), followed by abolishment of the 
G-CEPIA1er response to PF stimulation (Figures 11d and 11e, orange). This response was not 
due to any pH change in the ER, because the PF stimulation had no effect on pH within the 
ER measured by ER-targeted EYFP (Figures 9e–g) (65,66). Thus, subcellular ER Ca2+ 
imaging using CEPIA is applicable to tissue preparations that have retained three-dimensional 
structure, which often requires two-photon excitation. 
 
Simultaneous imaging of Ca
2+
 dynamics in the ER and cytosol 
For simultaneous imaging of Ca
2+
 dynamics in the ER and cytosol, the ratiometric 
small-molecule Ca
2+
 indicator, fura-2 (excitation: 340–380 nm) was used together with 
G-CEPIA1er or R-CEPIA1er. ER Ca
2+
 signals were mirror images of the cytosolic Ca
2+
 
oscillations (Figures 12a and 12b). Although G-CEPIA1er and R-CEPIA1er are weakly 
excited at the excitation wavelengths of fura-2 (Figures 5a and 13a), they had very little effect 
on the fura-2 fluorescence ratio (Figure 13b). Thus, it is possible to use G-CEPIA1er and 
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R-CEPIA1er with fura-2. Either G-CEPIA1er or GEM-CEPIA1er can be co-expressed with 
R-GECO1 for simultaneous imaging of the ER and cytosolic Ca
2+
 dynamics (Figures 12c–f). 
Reversal of the colors is also possible, and ER Ca
2+
 imaging using R-CEPIA1er can be 
simultaneously carried out with cytosolic Ca
2+
 imaging using G-GECO1.1 or GEM-GECO1 
(Figures 12g and 12h). Spectral bleed-through was minimal (<3%, Figure 13a). These results 
show the versatility of CEPIA as ER Ca
2+
 indicators. 
 
Imaging of store-operated Ca
2+
 entry 
Store-operated Ca
2+
 entry (SOCE) is a ubiquitous process to replenish ER Ca
2+
 by inducing 
Ca
2+
 influx from the extracellular space (14), and has been shown to play an important role in 
the activation of immune cells (13). SOCE has been previously analyzed by measuring the 
increase in cytosolic Ca
2+
 concentration ([Ca
2+
]cyt) after store depletion by SERCA inhibitors, 
such as thapsigargin and cyclopiazonic acid (CPA). However, it remains unclear whether 
SOCE induces an increase in [Ca
2+
]cyt under physiological conditions (69,70). Simultaneous 
Ca
2+
 imaging in the ER and cytosol using G-CEPIA1er and fura-2, respectively, provides a 
direct means to analyze Ca
2+
 dynamics during SOCE.  
I found that stimulation of HeLa cells with histamine in the absence of extracellular 
Ca
2+
 induced an increase in [Ca
2+
]cyt and concomitant partial depletion of [Ca
2+
]ER (Figure 14a, 
black lines). Removal of histamine resulted in a shift of [Ca
2+
]cyt to [Ca
2+
]ER in the continued 
absence of extracellular Ca
2+
. When Ca
2+
 was reintroduced to the extracellular space (“Ca2+ 
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add back”), a recovery of [Ca2+]ER toward the pre-stimulation level was seen. During ER 
refilling with Ca
2+
, the increase in [Ca
2+
]cyt was extremely small ([Ca
2+
]cyt = 4.8 ± 0.6 nM, 
Figures 14b–d) as compared with the large [Ca2+]cyt increase (241 ± 14 nM) observed after 
SERCA blockade by CPA or thapsigargin (Figures 14a and 14e). ER refilling was blocked by 
Gd
3+
, an Orai1 inhibitor (71) (Figure 14b, magenta lines). When STIM1 was extrinsically 
expressed in HeLa cells, the [Ca
2+
]cyt and ER Ca
2+
 recovery rate during “Ca2+ add back” were 
significantly elevated (Figures 15a and 15d). These results indicate that, in HeLa cells, Ca
2+
 
influx via SOCE is rapidly taken up by SERCA without forming a high-amplitude cytosolic 
Ca
2+
 signal unless STIM1 is overexpressed. I next examined Jurkat T cells stimulated with T 
cell receptor activation. In these cells, although Ca
2+
 influx via SOCE is partly taken up by 
SERCA as shown by the increase in [Ca
2+
]ER, there was a significant increase in the 
cytoplasmic Ca
2+
 concentration ([Ca2+]cyt = 539 ± 38 nM, Figure 14f). Thus, unlike in HeLa 
cells, the rate of Ca
2+
 influx via SOCE surpasses the ER Ca
2+
 uptake rate in Jurkat T cells, and 
SOCE is capable of inducing an increase in [Ca
2+
]cyt. 
 
CEPIA imaging simultaneous with other fluorescent molecules 
Simultaneous time-lapse imaging of [Ca
2+
]ER and other cellular processes should provide 
valuable information. I examined the possibility of simultaneously measuring [Ca
2+
]ER and 
the subcellular distribution of STIM1, which senses the ER luminal Ca
2+
 concentration and, 
upon ER Ca
2+
 depletion, translocates to the subplasma membrane region to oligomerize (14). 
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Accumulating evidence suggests that the oligomerization of STIM1, which appears as a 
punctate structure of fluorescent protein-tagged STIM1, is a key determinant of SOCE (72). 
I measured [Ca
2+
]ER using GEM-CEPIA1er and simultaneously imaged STIM1 
dynamics using mCherry-STIM1 (Figures 16a and 16b). Upon addition of histamine in the 
absence of extracellular Ca
2+
, [Ca
2+
]ER began to decrease in an almost linear fashion. The 
formation of STIM1 puncta was considerably delayed, being observed only after [Ca
2+
]ER fell 
below 600 µM. Thereafter, puncta formation proceeded alongside further decreases in 
[Ca
2+
]ER. When Ca
2+
 was added back to the extracellular solution after histamine washout, 
[Ca
2+
]ER refilling began and the mCherry-STIM1 puncta decomposed. The relationship 
between [Ca
2+
]ER and puncta formation could be fitted by Hill plot, with a Hill coefficient of 
7.9 and a K1/2 of 350 µM for puncta formation, and 9.7 and 530 µM for dissociation (Figure 
16c). Thus, the relationship between [Ca
2+
]ER and puncta formation/dissociation exhibits 
considerable hysteresis. The difference of K1/2 between puncta formation and dissociation was 
also observed using G-CEPIA1er and mCherry-STIM1 (Figures 15a–c). These observations 
indicate that, as far as [Ca
2+
]ER-dependent puncta formation of STIM1 is concerned, there is a 
threshold-like behavior, and suggest the existence of a mechanism that produces the delay in 
the dissociation of STIM1 puncta. Thus, CEPIA enables quantitative analysis of relationship 
between [Ca
2+
]ER and STIM1 dynamics. 
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Intercellular heterogeneity of mitochondrial Ca
2+
 signaling 
I examined whether CEPIA indicators can be utilized for Ca
2+
 imaging in mitochondria. To 
cover the broad range of mitochondrial Ca
2+
 concentrations (0.05–300 µM) (22,28,73), three 
CEPIA variants with different Ca
2+
 affinities were selected from the library: CEPIA2 (Kd = 
0.16 µM), CEPIA3 (11 µM), and CEPIA4 (59 µM) (Table 1a, Figures 6d and 17a). These 
indicators were expressed in HeLa cells by adding the mitochondrial localization signal 
sequence (29) (CEPIA2mt, CEPIA3mt and CEPIA4mt) to their coding sequences. The 
expression colocalized with MitoTracker Red and was distinct from the ER (Figure 17b). 
Histamine application to mobilize ER Ca
2+
 induced a rapid increase in mitochondrial 
Ca
2+
 levels followed by a slow decay (Figures 17c and 17d). This mitochondrial Ca
2+
 signal 
was abolished when the mitochondrial membrane potential was dissipated by carbonyl 
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (Figures 17c and 17d). 
Only a subpopulation of cells showed a mitochondrial Ca
2+
 response, and the fraction 
of responding cells decreased with the decreasing affinities of the CEPIAmt (Figures 17e–g). 
Enhancement of mitochondrial Ca
2+
, either by extrinsic expression of MCU or by suppression 
of Na
+
/Ca
2+
 exchanger-mediated mitochondrial Ca
2+
 clearance by CGP-37157, resulted in a 
striking increase in the fraction of cells displaying Ca
2+
 signals. Under these conditions, 
sustained or oscillatory mitochondrial responses were observed in a large fraction of cells, and 
obvious saturation of CEPIAmt was observed in many cells (Figures 17e and 17g). I 
concluded that CEPIAmt successfully reports mitochondrial Ca
2+
 signals, and that 
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mitochondrial Ca
2+
 dynamics during agonist stimulation have considerable cell-to-cell 
variation. 
 
Subcellular heterogeneity of mitochondrial Ca
2+
 response 
In a fraction of cells, agonist stimulation elicited a mitochondrial Ca
2+
 response throughout 
the cell. In the remaining cells, only a subpopulation of mitochondria responded with a Ca
2+
 
increase. For example, in the cell shown in Figures 18a–c, mitochondrial Ca2+ concentration 
([Ca
2+
]mt) measured with CEPIA3mt increased in region 2; the size of the increase was three 
times greater than that averaged over the entire cell. In contrast, there was no increase in 
[Ca
2+
]mt in region 1. To exclude the possibility of regional variation in the CEPIA3mt 
response, I applied a Ca
2+
 ionophore, ionomycin. The same response was observed in both 
regions 1 and 2. Subcellular heterogeneity in mitochondrial Ca
2+
 dynamics was also 
visualized by CEPIA2mt (Figures 18d–f). These results indicate that there is a considerable 
subcellular variation in the capacity of mitochondria to take up Ca
2+
. 
I tested a possible role for the ER in this inhomogeneous mitochondrial Ca
2+
 
response, since it has been postulated that ER Ca
2+
 release is important for mitochondrial Ca
2+
 
responses (9). To this end, simultaneous Ca
2+
 imaging of the cytosol, ER and mitochondria 
was performed using GEM-GECO1, G-CEPIA1er and R-GECO1mt, respectively. Agonist 
stimulation induced a marked increase in [Ca
2+
]mt in region 2 but not in adjacent mitochondria, 
including those in region 1. In contrast to the inhomogeneous mitochondrial response, 
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[Ca
2+
]ER and [Ca
2+
]cyt showed similar responses in regions 1 and 2 (Figure 19). I also 
examined the subcellular heterogeneity in mitochondrial pH or membrane potentials (Ψm) as a 
potential mechanism of heterogeneous mitochondrial Ca
2+
 responses (74-76). Simultaneous 
measurement of [Ca
2+
]mt and pHmt indicated that inhomogeneous Ca
2+
 responses are not due 
to pH changes (Figures 20a–d). Neither did I find any heterogeneity in Ψm, corresponding to 
mitochondrial Ca
2+
 responses (Figures 20e–f). These results suggest that the inhomogeneous 
mitochondrial Ca
2+
 response is generated by heterogeneity in the strength of 
ER-mitochondrial coupling or in the regulation of Ca
2+
 uptake protein rather than in the 
amount of Ca
2+
 released from the local ER or in pH or Ψm. 
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Discussion 
 
Ca
2+
 concentrations within the ER and mitochondria control cytosolic Ca
2+
 dynamics and 
regulate cell functions including ER stress and cell death (3,8). Methods such as CEPIA that 
obtain direct information about intraorganellar Ca
2+
 dynamics are, therefore, of great 
importance. The merits of CEPIA indicators for imaging ER or mitochondrial Ca
2+
 
concentrations can be summarized as follows. First, they have very high dynamic range and 
spatiotemporal resolution. This has allowed, for instance, the first imaging of an inverse Ca
2+
 
wave and synaptic activity-dependent ER Ca
2+
 dynamics in neurons. Second, CEPIA allows 
simultaneous Ca
2+
 imaging in the ER, mitochondria and cytosol with subcellular resolution. 
Third, CEPIA indicators are applicable to many cell types including intact neurons. Fourth, 
ratiometric measurement is possible with GEM-CEPIA1er, whereby intraorganellar Ca
2+
 
concentrations can be determined independent of the indicator’s expression level. Fifth, the 
high signal-to-noise ratio and one-wave length measurement with G-CEPIA1er and 
R-CEPIA1er reduce the technical difficulty of organellar Ca
2+
 imaging and obviate the 
requirement for a special imaging apparatus. Thus, CEPIA-mediated imaging methods should 
have broad utility in many cell biological studies. Indeed, work described in this paper 
addresses important cell functions. Furthermore, in a recent study CEPIA is successfully used 
to prove that abnormal ER Ca
2+
 handling is associated with disease-related mutations of the 
RyR (77). 
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Influx of Ca
2+
 from the extracellular space to the cytoplasm through SOCE is found 
in many types of cells (13,78). The inhibition of SERCA (an ER Ca
2+
 pump) by 
pharmacological means, such as thapsigargin and CPA, to deplete ER Ca
2+
 has been the 
standard method to study the SOCE mechanism (13). Now, using CEPIA, I have studied 
SOCE under physiological conditions, without SERCA inhibition. This revealed that [Ca
2+
]cyt 
is held constant during SOCE activation in HeLa cells, although [Ca
2+
]ER is sufficiently low to 
induce significant [Ca
2+
]cyt increase when SERCA is inhibited. These results indicate that the 
balance between the SOCE and SERCA activities is important for the capacity of SOCE to 
induce sustained increase in [Ca
2+
]cyt. In HeLa cells, SERCA activity is sufficiently high to 
take up Ca
2+
 influx through SOCE. However, the balance can differ between cell types, and if 
it favors Ca
2+
 influx there may be a large increase in [Ca
2+
]cyt during SOCE activation. Indeed, 
I found that the balance favors Ca
2+
 influx in Jurkat T cells, being consistent with the 
importance of SOCE in immune cells (13). 
SOCE is a remarkable mechanism, in which [Ca
2+
]ER regulates the Ca
2+
 
permeability in the plasma membrane. The ER Ca
2+
 transducer of SOCE is STIM1, which 
senses [Ca
2+
]ER and translocates to the subplasmalemmal ER domain to form punctate 
structures and recruit Orai1 for Ca
2+
 influx through the plasma membrane. The steady-state 
[Ca
2+
]ER dependence of the amplitude of ionic current carried by SOCE (ICRAC) and the 
subplasmalemmal translocation of STIM1 has been quantified (79). ICRAC and STIM1 
translocation were found to be nonlinear functions of [Ca
2+
]ER with a Hill coefficient of ~4 
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and a K1/2 of ~200 µM. This is consistent with the dissociation constant of the Ca
2+
-binding 
domain (EF-SAM) of STIM1 measured with a 
45
Ca
2+
 binding assay (Kd = ~250 μM) (80). 
STIM1 deoligomerization for the termination of SOCE is thought to be mediated by ER Ca
2+
 
refilling (14). Comparisons of the [Ca
2+
]ER dependence of STIM1 puncta formation and 
dissociation have shown that the K1/2 of STIM1 puncta dissociation is lower than that of 
formation (81,82). However, in these studies, STIM1 dynamics and [Ca
2+
]ER had to be 
measured in separate cells, because both signals were measured using FRET between YFP 
and CFP. I found that extrinsic expression of STIM1 significantly increases both [Ca
2+
]cyt and 
ER Ca
2+
 refilling rate during SOCE. Thus, the comparison between cells with and without 
STIM1 expression requires caution. To circumvent this problem, I simultaneously measured 
STIM1 puncta formation/dissociation and [Ca
2+
]ER in the same cells. Both STIM1 puncta 
formation and dissociation were highly nonlinear functions of [Ca
2+
]ER. Furthermore, the K1/2 
of [Ca
2+
]ER for puncta dissociation was greater than that for formation (530 and 350 µM for 
dissociation and formation, respectively). These results indicate that the STIM1 
deoligomerization process is not a simple reversal reaction of STIM1 oligomerization. 
Within neurons the ER forms a continuous network throughout the cell (described 
as “a neuron within a neuron” (2,83)) that produces slowly-propagating regenerative Ca2+ 
signals using a conduction system based on IP3R and RyR. However, neuronal ER Ca
2+
 
dynamics have previously been estimated only indirectly, by cytosolic Ca
2+
 imaging. In this 
study, G-CEPIA1er was successfully used to visualize Ca
2+
 dynamics in the neuronal ER, in 
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response to synaptic inputs to Purkinje cell dendrites in cerebellar slice preparations. 
Subsequent study using G-CEPIA1er indicated that Ca
2+
 diffusion within the ER (Ca
2+
 
tunneling) is critical for the replenishment of ER Ca
2+
 after synaptic inputs in cerebellar 
Purkinje cells (84). Neuronal ER Ca
2+
 dynamics are important for physiological functions 
such as synaptic plasticity (83), but also for pathophysiological states including 
neurodegenerative diseases (8,85). Thus, the application of CEPIA to intact neurons should 
provide a new imaging modality to analyze brain function. 
Accumulating evidence suggests that Ca
2+
 dynamics in mitochondria are involved 
in the regulation of cell physiology and pathology, including autophagy, cell death, ATP 
synthesis, mitochondrial morphology and neurodegenerative diseases (3,12). Mitochondria 
constantly undergo fusion and fission for the maintenance of functions (86). Thus, subcellular 
inhomogeneity in mitochondrial functions is of great importance. Intracellular inhomogeneity 
in mitochondrial Ca
2+
 dynamics was first proposed based on mitochondria-targeted aequorin 
measurements (87), although these measurements did not have spatial resolution, and the 
inhomogeneity was inferred from the partial consumption of aequorin. Later, 
mitochondria-targeted GECIs were used to image the subcellular mitochondrial Ca
2+
 response 
following agonist-induced ER Ca
2+
 release (21,22,26). These studies revealed that, after a 
rapid increase in [Ca
2+
]mt in response to agonist stimulation, there is a considerable variation 
in the decay timecourse among the subpopulation of mitochondria within the cell, and a few 
minutes after the agonist stimulation only a minor subpopulation of mitochondria retained the 
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increase in [Ca
2+
]mt (21,22,26). The results obtained in this study showed that there is 
considerable intercellular and intracellular inhomogeneity in mitochondrial Ca
2+
 responses 
after agonist-induced Ca
2+
 release from the ER through IP3Rs, despite the fact that consistent 
cytosolic Ca
2+
 increases were observed. These results are consistent with the observation 
using a small molecular Ca
2+
 indicator (88). Furthermore, simultaneous Ca
2+
 imaging of the 
ER and mitochondria did not show any inhomogeneous ER Ca
2+
 release. The inhomogeneity 
of the restingΨm did also not correlate with the inhomogeneity of Ca
2+
 signal. These findings 
indicate that mitochondrial Ca
2+
 responses involve more than simple, passive uptake of 
cytosolic Ca
2+
; there must be a regulatory mechanism for Ca
2+
 uptake. One possibility is that 
recently-identified MCU (3,89,90) and its associate proteins such as mitochondrial calcium 
uptake 1 (MICU1) (57), Mitochondrial Calcium Uniporter Regulator 1 (MCUR1) (91), MCU 
regulatory subunit (MCUb) (92), and essential MCU regulator (EMRE) (93) as well as 
H
+
/Ca
2+
 exchanger, Na
+
/Ca
2+
 exchanger (3) are regulated in a subcellular region-specific 
manner. Another possibility is that ER-mitochondria tethering proteins such as mitofusin 2 
(12) are inhomogeneously distributed allowing region-specific transfer of Ca
2+
 from the ER to 
mitochondria at the ER-mitochondrial junction (10,11). Further studies using CEPIA will 
provide clues to the mechanism coupling between the ER and mitochondria. 
I created fifty-eight variants of cfGCaMP2 and studied how their fluorescence 
intensity related to Ca
2+
 levels. This work shed light on the structure-function relationship of 
CaM-based indicators. Previous studies have reported that highly conserved glutamate 
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residues at –Z position in each EF-hand motif are key determinants of the Ca2+ sensitivity of 
CaM-based Ca
2+
 indicators (15,17,94). Here I further established that the substitution of 
glutamate with a non-acidic amino acid (E31A or E31Q) reduces not only the Ca
2+
 binding 
affinity but also the dynamic range of the indicator. In contrast, conservative substitutions to 
aspartate reduced the Ca
2+
 binding affinity, while maintaining the dynamic range. In line with 
this observation, a previous report showed that charge-reversing substitutions (E31K or 
E67K) resulted in a reduction of the dynamic range of GCaMP (94). These results suggest 
that the acidic residue in –Z position is not only the key determinant of Ca2+ binding affinity, 
but is also important for the efficient conformational change upon Ca
2+
 binding (62). F92W 
and D133E substitutions that reduce Ca
2+
 binding affinity without affecting the dynamic 
range have been previously reported for proteins possessing CaM-dependent enzymatic 
activity (61). Combining these two types of substitutions synergistically reduced Ca
2+
 binding 
affinity, which led to the generation of CEPIA indicators. This strategy may be applicable for 
the generation of ER and mitochondrial Ca
2+
 indicators based on other CaM-based indicators. 
Other groups also developed ER-targeted GECIs on the basis of GCaMP or GECO 
with amino acids substitutions different from CEPIA. ER-LAR-GECO1 was generated by 
combined strategies of random and site-directed mutagenesis on the CaM-M13 interaction 
sites in R-GECO1 (34). GCaMPer (10.19) was created by introducing multiple mutations in 
the Ca
2+
 binding sites of GCaMP3 (35). Both indicators are successfully used to detect ER 
Ca
2+
 signals similar with CEPIA. The amino acid substitutions used in these indicators may 
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have a potential to be used for further improvement of CEPIA by combined with mutations in 
CEPIA library. 
In summary, CEPIA-based imaging will contribute to the understanding of 
intraorganellar dynamics of Ca
2+
, and thus to elucidation of the functions of the ER and 
mitochondria in a variety of cells. 
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Figure Legends 
 
Figure 1. Construction of CEPIA1er. 
(a) Scatter chart of cfGCaMP2 variants with respect to Ca
2+
 affinity (Kd) and dynamic range 
(Fmax/Fmin). Introduced amino acid substitutions are categorized by color: original cfGCaMP2 
(black), substitutions of previously reported ER Ca
2+
 indicators (gray, green and light green), 
a substitution at single –Z position (cyan), substitutions in multiple –Z positions (blue), 
substitutions at F92W and/or D133E (orange), combinational substitutions at –Z positions and 
F92W/D133E (magenta). Data point for CEPIA1er is indicated by an arrow. Putative range of 
Ca
2+
 concentration in the ER is indicated (gray box). 
(b) In vitro Ca
2+
 titration curves of the recombinant proteins of the original cfGCaMP2 
(black) and its variants (gray or green, n = 58). For clarity, only the fitted Hill plot curves 
were shown except for CEPIA1er. Putative ranges of Ca
2+
 concentration in the cytosol and 
ER are indicated (gray boxes). 
(c) Schematic domain structure of CEPIA1er. Four amino acid substitutions (E31D, F92W, 
E104D and D133E) were introduced to the CaM of cfGCaMP2 (black). ER signal sequence 
from immunoglobulin heavy-chain variable regions of the mouse and ER retention signal 
(SEKDEL) were attached at the N and C termini, respectively (gray). 
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(d) Subcellular distribution of CEPIA1er and ER-targeted mCherry (with calreticulin signal 
sequence) in a HeLa cell. Note that the ER-signal sequence in CEPIA1er is different from that 
of mCherry-er. The images within the white boxes were expanded. 
(e) ER Ca
2+
 depletion induced by 3 µM thapsigargin in HeLa cells visualized with CEPIA1er. 
The fluorescence intensity was normalized by the resting value. Representative trace of 20 
cells. 
(f) Oscillatory ER Ca
2+
 dynamics in response to 10 µM histamine stimulation in HeLa cells 
visualized with CEPIA1er. The fluorescence intensity was normalized by the resting value. 
Representative trace of 49 cells. 
 
Figure 2. Characterization of CEPIAer. 
(a) In vitro Ca
2+
 titration curves of CEPIA1er (black solid), G-CEPIA1er (green solid), 
R-CEPIA1er (magenta solid), GEM-CEPIA1er (blue solid) compared with cfGCaMP2 (black 
dotted), G-GECO1.1 (green dotted), R-GECO1 (magenta dotted), GEM-GECO1 (blue dotted) 
and D1ER (orange). Fitted Hill plot curves are shown. Putative ranges of Ca
2+
 concentration 
in the cytosol and ER are indicated (gray boxes). 
(b–d) Representative images of HeLa cells expressing G-CEPIA1er (b), R-CEPIA1er (c) or 
GEM-CEPIA1er (b). Images were compared with the co-expressed ER-targeted mCherry (b 
and d) or EGFP (c), which were targeted to the ER with calreticulin signal sequence and ER 
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retention signal. Note that the ER signal sequence in CEPIAer is different from that of 
mCherry-er and EGFP-er. The images within the white boxes were expanded. 
 
Figure 3. Comparison of amino acid sequences in the CaM domains of CEPIAer with 
those of GCaMP2, cfGCaMP2 and GECOs. 
CaM domains of GCaMP2, cfGCaMP2, CEPIA1er, G-GECO1.1, G-CEPIA1er, R-GECO1, 
R-CEPIA1er, GEM-GECO1 and GEM-CEPIA1er were described. The gray boxes indicate 
the four Ca
2+
 binding loops in the CaM. Amino acids substituted from GCaMP2 are 
highlighted with colors (magenta, substitutions at –Z positions of Ca2+ binding loops; orange, 
F92W or D133E substitutions; blue, substitutions to generate cfGCaMP2; green, substitutions 
to generate GECOs). 
 
Figure 4. Genealogy of CEPIA variants. 
CEPIA1er, CEPIA3mt and CEPIA4mt were generated by introducing amino acid 
substitutions into the CaM domain of cfGCaMP2. G-CEPIA1er was generated by replacing 
the CaM domain of G-GECO1.1 with that of CEPIA1er. For the generation of R-CEPIA1er, 
the CaM domain of R-GECO1 was first replaced with those of cfGCaMP2 variants, and 
subsequently amino acid substitutions were introduced into the CaM domains of the 
R-GECO1 variants. GEM-CEPIA1er was created by introducing amino acid substitutions into 
the CaM domain of GEM-GECO1. 
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Figure 5. Spectral properties of CEPIAer. 
(a) Spectral titration curves of CEPIAer at various Ca
2+
 concentrations. The fluorescence 
intensity was normalized by the maximum intensity. For emission spectra, G-CEPIA1er, 
R-CEPIA1er and GEM-CEPIA1er were excited at 488, 562 and 395 nm, respectively. For 
excitation spectra, fluorescence intensity at 512 and 584 nm was obtained for G-CEPIA1er 
and R-CEPIA1er, respectively, and at 460 and 510 nm for GEM-CEPIA1er. 
(b) Absorbance spectra of CEPIAer (upper panels) and original GECO (lower panels) in 
Ca
2+
-containing (5 mM, magenta) or Ca
2+
-free (1 mM EGTA, black) solution. 
 
Figure 6. In vitro properties of CEPIAer. 
(a) pH titration curves of CEPIAer. The fluorescence intensity or ratio was normalized within 
the maximum and minimum values. pKa was evaluated by the pH titration in Ca
2+
-containing 
(magenta) or Ca
2+
-free (black) solution. The plots of G-CEPIA1er, G-GECO1.1 and 
R-GECO1 were fitted by a single Hill plot equation. The plots of R-CEPIA1er, 
GEM-CEPIA1er and GEM-GECO1 were fitted by a double Hill plot equation. All the 
extracted parameters are summarized in Table 2. 
(b) Mg
2+
 titration curves of CEPIAer (magenta) compared with Ca
2+
 titration curves (black). 
The fluorescence intensity was normalized by the values in Mg
2+
 and Ca
2+
 free solution. 
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(c) Ca
2+
 titration of G-CEPIA1er (green), R-CEPIA1er (magenta) and GEM-CEPIA1er (blue) 
plotted against linear [Ca
2+
]ER scale. Fitted Hill plot curves are also shown. Putative range of 
Ca
2+
 concentration in the ER is indicated (gray box). 
(d) Ca
2+
 titration of CEPIA2–4mt plotted against linear Ca2+ concentration scale. Fitted Hill 
plot curves are also shown. 
 
Figure 7. Visualization of ER Ca
2+
 dynamics using CEPIAer. 
(a) Comparison of the responses of CEPIA1er, G-CEPIA1er, R-CEPIA1er, GEM-CEPIA1er 
and D1ER to thapsigargin (3 µM)-induced depletion of ER Ca
2+
 in HeLa cells (mean ± s.e.m., 
12–31 cells; ***, P < 0.001). Amplitude is defined as the extent of maximum decrease in the 
fluorescence intensity or ratio after thapsigargin application normalized by the resting value 
(ΔF/F0 or ΔR/R0). For comparison, the response of CEPIA1er displayed in Figure 1e is shown 
(gray). 
(b) ER Ca
2+
 dynamics in response to histamine (10 µM) measured with CEPIA1er, 
G-CEPIA1er, R-CEPIA1er, GEM-CEPIA1er and D1ER (mean ± s.e.m., 14–103 cells; ***, P 
< 0.001). Amplitude is defined as the maximum decrease in F/F0 or R/R0 within 30-s time 
window after histamine application. For comparison, the response of CEPIA1er displayed in 
Figure 1f is shown (gray). 
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(c) Representative traces of the histamine-induced ER Ca
2+
 dynamics visualized with 
GEM-CEPIA1er in HeLa cells. Absolute [Ca
2+
]ER (upper) was estimated from the ratio of the 
green to blue fluorescence intensities (middle and bottom). 
(d) Cell type-specific variations of absolute [Ca
2+
]ER measured with GEM-CEPIA1er. Box 
plots for [Ca
2+
]ER in a variety of cell types before and after agonist stimulation (10 μM 
histamine for HeLa cells, 30 μM ATP for HEK cells and cultured astrocytes, and 100 nM 
bradykinin for BHK cells; 4–19 cells) were shown. [Ca2+]ER after agonist stimulation 
indicated the minimum value reached within 30 s after agonist application. The horizontal line 
within the box represents the median value, the upper and lower edges of the box represent 
75% and 25% values and the whiskers represent the total range. 
 
Figure 8. in situ Ca
2+
 titration of CEPIAer. 
(a and b) To determine the Ca
2+
 affinity of CEPIAer within the ER, HeLa cells expressing 
one of CEPIAer (G-CEPIA1er, R-CEPIA1er or GEM-CEPIA1er) were permeabilized with 
150 µM β-escin in a solution containing 3 μM thapsigargin and 3 μM ionomycin. Then Ca2+ 
concentration in the bathing solution was increased in a stepwise manner. Plots are fitted with 
a Hill equation. For comparison, the in vitro properties of CEPIAer displayed in Table 2 are 
shown. 
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Figure 9. CEPIAer responses are independent of ER pH dynamics.  
(a) Representative images of HeLa cells expressing EYFP-er (upper), R-CEPIA1er (middle) 
and the merged image (lower). The images within the white boxes were expanded. 
(b) Simultaneous measurement of EYFP-er (green) and R-CEPIA1er (gray) in HeLa cells 
stimulated with 10 µM histamine. 
(c) pH-dependent change of EYFP-er fluorescence intensity in HeLa cells. The cells were 
first bathed in an acidic solution (pH 6.8) containing monensin (10 µM) and nigericin (10 
µM), and subsequently in an alkalinization solution (30 mM NH4Cl). 
(d) Summary of EYFP-er and R-CEPIA1er responses (mean ± s.e.m., 14 cells). 
(e) Dendrites of EYFP-er-expressing Purkinje cells. The magenta circle (10 µm diameter, 
under the stimulation pipette) indicates the region of interest for panel f. 
(f) The time course of fluorescence intensity change of EYFP-er (green) upon PF inputs (ten 
stimuli at 100 Hz, gray vertical line). For comparison, the fluorescence intensity change of 
G-CEPIA1er displayed in Figure 11b is shown (gray). 
(g) Summary of PF-induced responses of G-CEPIA1er and EYFP-er. Amplitude is defined as 
the maximum decrease in ΔF/F0 within the 3-s time window after PF stimulation (mean ± 
s.e.m., eight cells for both G-CEPIA1er and EYFP-er). 
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Figure 10. Wave-like propagation of ER Ca
2+
 release visualized with G-CEPIA1er. 
(a) Time-lapse images of wave-like decrease in the ER Ca
2+
 concentration visualized with 
G-CEPIA1er. Perfusion of 10 µM histamine was started at 0 s. 
(b) Time course of ER Ca
2+
 dynamics along the white line in a. 
(c) Comparison of ER Ca
2+
 dynamics in two regions of interest indicated in a. The 
fluorescence intensity was normalized by the initial intensity. Black line: region 1; green line: 
region 2. 
(d) The velocity of ER Ca
2+
 wave measured with G-CEPIA1er (mean ± s.e.m., 23 cells) or 
R-CEPIA1er (20 cells). For comparison, the velocity of cytosolic Ca
2+
 wave measured with 
fluo-4 in cells without (Fluo-4; eight cells) or with R-CEPIA1er expression (Fluo-4 + 
R-CEPIA1er; six cells). There was no significant statistical difference among these values (P 
= 0.93, one-way ANOVA). 
 
Figure 11. Activity-dependent ER Ca
2+
 dynamics in cerebellar Purkinje cells visualized 
with G-CEPIA1er. 
(a) Representative images of G-CEPIA1er-expressing Purkinje cells in the cerebellar slice. 
(b) PF-induced ER Ca
2+
 dynamics in the dendrites of Purkinje cells. Representative time 
course of mean F/F0 within the white circle (indicated in the left image) indicates 
fluorescence decrease upon PF inputs (ten stimuli at 100 Hz, gray vertical line). The 
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pseudo-color image that is the average of 10 consecutive frames (indicated as magenta in the 
time course of F/F0) shows local dynamics of luminal Ca
2+
. 
(c) PF-induced response in a single spine of Purkinje cells. Representative time course of 
F/F0 within a spine indicated by the arrow. PF inputs (ten stimuli at 100 Hz, gray vertical 
line) elicited ER Ca
2+
 release within the spine. 
(d) Pharmacological characterization of PF-induced ER Ca
2+
 dynamics. G-CEPIA1er 
responses are shown upon PF inputs (five stimuli at 100 Hz, gray vertical line) in the control 
condition (black); in the presence of LY367385 (100 μM, blue) or NBQX (10 μM, magenta); 
or after the ER Ca
2+
 depletion with CPA (50 μM, orange). 
(e) Summary of PF-induced ER Ca
2+
 dynamics. Amplitude is defined as the maximum 
decrease in ΔF/F0 within the 3-s time window after PF stimulation (mean ± s.e.m., 7–12 
cells). 
(f) CPA-induced ER Ca
2+
 depletion. The application of 50 μM CPA decreased G-CEPIA1er 
fluorescence with the ΔF/F0 amplitude of 0.43 ± 0.021 (mean ± s.e.m., six cells). 
 
Figure 12. Simultaneous measurement of Ca
2+
 signals in the ER and cytosol using 
CEPIAer and cytosolic Ca
2+
 indicators. 
(a and b) Simultaneous measurement of Ca
2+
 signals in the ER (G-CEPIA1er or 
R-CEPIA1er) and cytosol (fura-2) in HeLa cells stimulated with 10 µM histamine. 
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(c–f) Simultaneous Ca2+ imaging in the ER (G-CEPIA1er or GEM-CEPIA1er) and cytosol 
(R-GECO1) in a HeLa cell (c), an astrocyte (d), a BHK cell (e) or a HEK293A cell (f), 
stimulated with 10 µM histamine (c), 30 µM ATP (d and f) or 100 nM bradykinin (e), 
respectively. 
(g and h) Simultaneous Ca
2+
 imaging in the ER (R-CEPIA1er) and cytosol using G-GECO1.1 
(g) or GEM-GECO1 (h) in HeLa cells stimulated with 10 µM histamine. 
 
Figure 13. Evaluation of bleed-through of CEPIA, GECO and fura-2. 
(a) Representative traces of fluorescence intensity changes in response to histamine 
application at six pairs of excitation and emission wavelengths (472/520, 562/641, 377/466, 
377/520, 340/510 and 365/510 nm) in HeLa cells expressing one of the genetically encoded 
indicators or loaded with fura-2. Autofluorescence was subtracted. 
(b) Comparisons of the resting and agonist-induced peak fura-2 ratios among the cells 
expressing G-CEPIA1er (green; mean ± s.e.m., 18 cells), R-CEPIA1er (magenta; 25 cells), 
CEPIA2mt (light green; 16 cells) and cells without CEPIA expression (gray; 68 cells). There 
were no significant differences in the resting and peak fura-2 ratios. P = 0.51 and 0.40, 
one-way ANOVA. 
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Figure 14. Visualization of ER and cytosolic Ca
2+
 dynamics during store-operated Ca
2+
 
entry (SOCE). 
(a and b) Ca
2+
 dynamics in the ER (lower panels) and cytosol (upper panels) during SOCE. 
After histamine (10 µM)-induced Ca
2+
 release in the absence of extracellular Ca
2+
, SOCE was 
induced by “Ca2+ add back”, the reintroduction of Ca2+ in the extracellular solution (black). 
To evaluate the contribution of SERCA-dependent Ca
2+
 uptake by the ER, CPA was applied 
as indicated to the extracellular solution (a, magenta). The ER Ca
2+
 refilling was inhibited by 
Gd
3+
 (10 μM), an inhibitor of Orai1, during “Ca2+ add back” (b, magenta). 
(c) Magnified [Ca
2+
]cyt traces during “Ca
2+
 add back” in the upper panel of b. 
(d) Changes in the ER Ca
2+
 refilling rate and [Ca
2+
]cyt in response to “Ca
2+
 add back” with or 
without Gd
3+
 application. Left, the slope of linear fitting to the G-CEPIA1er fluorescence 
change during the intervals T1 to T3 in b (lower panel) was obtained, and the indicated 
differences are shown. Right, the average [Ca
2+
]cyt during the intervals T1 to T3 in b (upper 
panel) and c was obtained, and the indicated differences are shown (mean ± s.e.m., 35 cells 
for control and 42 cells for Gd
3+
; ***, P < 0.001.) 
(e) Time courses of cytosolic (upper panel) and ER (lower panel) Ca
2+
 responses to 
thapsigargin (3 μM) treatment in HeLa cells in the absence of extracellular Ca2+, and to 
subsequent “Ca2+ add back” in the extracellular solution. 
(f) Time courses of cytosolic (upper panel) and ER (lower panel) Ca
2+
 responses to 
anti-human CD3ε monoclonal antibody (1 μg/ml, R&D systems, USA) treatment in Jurkat T 
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cells in the absence of extracellular Ca
2+, and to subsequent “Ca2+ add back” in the 
extracellular solution. 
 
Figure 15. Simultaneous imaging of STIM1 localization and Ca
2+
 concentration in the 
ER and cytosol. 
(a) Simultaneous imaging of STIM1 dynamics, ER Ca
2+
 level and cytosolic Ca
2+
 
concentration using mCherry-STIM1, G-CEPIA1er and fura-2, respectively. Time courses of 
cytosolic Ca
2+
 concentration (blue), ER Ca
2+
 dynamics (green) and the number of 
mCherry-STIM1 puncta normalized with the minimum and maximum (magenta). As [Ca
2+
]ER 
was depleted with histamine stimulation in the Ca
2+
-free solution, mCherry-STIM1 formed 
puncta. After Ca
2+
 addback in the external solution, [Ca
2+
]ER gradually recovered and 
mCherry-STIM1 puncta disappeared. The slope of linear fitting to the G-CEPIA1er 
fluorescence change and the average [Ca
2+
]cyt change during the time interval between T1 to 
T2 (shown in a) were calculated. 
(b) The images of fura-2 (upper), G-CEPIA1er (middle) and mCherry-STIM1 (lower) at four 
time points indicated in a as gray dotted lines. The expanded images of 
mCherry-STIM1within the white boxes were shown. 
(c) The normalized number of mCherry-STIM1 puncta was plotted against normalized 
G-CEPIA1er fluorescence (F/F0) during puncta formation (black) and dissociation (magenta). 
The relationship between [Ca
2+
]ER and puncta formation can be fitted by a Hill equation with 
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a Hill coefficient of 8.7 ± 1.1 and a K1/2 of 0.37 ± 1.1 for puncta formation, and 6.8 ± 0.6 and 
0.60 ± 0.04 for puncta dissociation (mean ± s.e.m., six cells). 
(d) Comparison of the ER Ca
2+
 refilling rate and [Ca
2+
]cyt in response to “Ca
2+
 add back” 
between STIM1-expressing cells and control cells. Left, the slope of linear fitting to the 
G-CEPIA1er fluorescence change during the time interval between T1 to T2 in a (middle 
panel) was shown. Right, the average [Ca
2+
]cyt change during the time interval between T1 to 
T2 in a (upper panel) was shown. Mean ± s.e.m., 35 cells for control and six cells for 
STIM1-expressing cells; ***, P < 0.001. 
 
Figure 16. Simultaneous imaging of STIM1 localization and absolute ER Ca
2+
 
concentration. 
(a) The images of GEM-CEPIA1er (upper) and mCherry-STIM1 (middle) at three time points 
indicated in b as gray dotted lines (T1, T2 and T3). The expanded images of 
mCherry-STIM1within the white boxes were shown in the lower panels. 
(b) Time courses of ER Ca
2+
 concentration (blue) and the number of mCherry-STIM1 puncta 
normalized with the minimum and maximum (magenta). As [Ca
2+
]ER was depleted with 
histamine stimulation in the Ca
2+
-free solution, mCherry-STIM1 formed puncta (T2). After 
Ca
2+
 addback in the external solution, [Ca
2+
]ER gradually recovered and mCherry-STIM1 
puncta disappeared (T3). 
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(c) The normalized number of mCherry-STIM1 puncta was plotted against ER Ca
2+
 
concentration during puncta formation (black) and dissociation (magenta). The plots obtained 
from three independent experiments were overlaid. The relationship between [Ca
2+
]ER and 
puncta formation can be fitted by a Hill equation with a Hill coefficient of 7.9 and a K1/2 of 
350 µM for puncta formation, and 9.7 and 530 µM for puncta dissociation. 
 
Figure 17. Intercellular heterogeneity of mitochondrial Ca
2+
 signal visualized with 
CEPIA. 
(a) Ca
2+
 titration curves of three mitochondria-targeted CEPIA variants (CEPIA2mt, Kd = 160 
nM, Fmax/Fmin = 1.7; CEPIA3mt, 11 μM, 1.6; CEPIA4mt, 56 μM, 1.5). The measurements 
were performed at pH 8.0. 
(b) Representative images of HeLa cells expressing CEPIA2mt (left) co-stained with 
MitoTracker Red (middle). The merged images are shown in the right panels. The areas 
within the white boxes were expanded (lower). 
(c) Representative traces of CEPIA2mt fluorescence upon histamine (10 μM) application in 
HeLa cells pre-stimulated with DMSO (gray) or FCCP (magenta, 500 nM; Abcam, USA). 
(d) Summary of CEPIA2mt response. Amplitude is defined as the extent of maximum 
increase in the fluorescence intensity after histamine application normalized by the resting 
value (ΔF/F0). Mean ± s.e.m.; 11 cells for vehicle only (DMSO) and 15 cells for FCCP. 
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(e) Representative traces of mitochondrial Ca
2+
 dynamics upon stimulation with histamine (10 
µM) in HeLa cells. To enhance mitochondrial Ca
2+
 signal, rat MCU was extrinsically 
expressed (+MCU, blue), or the inhibitor of Na
+
/Ca
2+
 exchanger CGP-37157 (10 µM; Enzo 
Life Sciences, USA) was applied (+CGP, magenta). 
(f) The percentage of cells showing mitochondrial Ca
2+
 responses upon histamine application 
measured with CEPIA2–4mt among control HeLa cells, MCU-expressing cells (+MCU) and 
CGP-37157-pretreated cells (+CGP). 
(g) Mitochondrial Ca
2+
 responses measured with CEPIA2–4mt during histamine (10 µM) 
stimulation were compared among control HeLa cells (67, 45 and 35 cells), MCU-expressing 
cells (26, 28 and 22 cells) and CGP-37157-pretreated cells (19, 24 and 16 cells). The response 
patterns were classified into five groups: rapid increase followed by slow decay (green), 
saturated response (magenta), sustained increase without saturation (orange), oscillatory 
response (blue) and no response (gray). 
 
Figure 18. Subcellular heterogeneity of mitochondrial Ca
2+
 signal visualized with 
CEPIAmt. 
Mitochondrial Ca
2+
 signals visualized with subcellular resolution using CEPIA3mt (a–c) or 
CEPIA2mt (d–f). (a and d) Upper, fluorescence images of HeLa cell expressing CEPIA3mt 
(a) or CEPIA2mt (d). Lower, the areas within the white boxes were expanded. 
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(b and e) Time courses of mitochondrial Ca
2+
 signal during histamine (10 μM) application 
and subsequent ionomycin (3 μM) stimulation within the two regions of interest shown in a 
and d. Time courses averaged over the entire cell were also shown (Global).  
(c and f) Upper, averaged fluorescence images at resting state (left), after histamine 
application (middle) and after ionomycin application (right) were indicated. Lower, 
time-dependent changes in the fluorescence intensity were shown in pseudo-color. 
 
Figure 19. Simultaneous Ca
2+
 imaging in the ER, mitochondria and cytosol during 
heterogeneous mitochondrial Ca
2+
 signal. 
(a) Fluorescence images of a HeLa cell expressing G-CEPIA1er (green) and 
mitochondria-localized R-GECO1 (R-GECO1mt, magenta). The area within the white box 
was expanded (right). 
(b) Time courses of Ca
2+
 signal in the mitochondria, ER and cytosol in a HeLa cell stimulated 
with 10 µM histamine within the two regions of interest indicated in a. Time courses averaged 
over the entire cell were also shown (Global). 
(c) The images of R-GECO1mt (magenta) and G-CEPIA1er (green) at three time points were 
shown. Perfusion of 10 µM histamine was started at 0 s. Representative images of six cells. 
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Figure 20. Evaluation of heterogeneity in mitochondrial matrix pH and mitochondrial 
inner membrane potential during heterogeneous mitochondrial Ca
2+
 signal. 
(a) Representative images of HeLa cells expressing R-GECO1mt (upper) and a 
mitochondria-targeted pH indicator SypHer-dmito (lower). The regions within the white 
boxes were expanded (right). 
(b) Time courses of R-GECO1mt (upper) and SypHer-dmito (lower) upon histamine (10 μM) 
stimulation within the two regions of interest indicated in a. 
(c) Representative trace of pH dependent change of SypHer-dmito fluorescence ratio in the 
region 1 indicated in a. The cells expressing SypHer-dmito were alkalinized with a solution 
containing 30 mM NH4Cl. 
(d) Summary of SypHer-dmito responses. Mitochondria showing Ca
2+
 signal upon histamine 
stimulation were analyzed. R/R0 after histamine and NH4Cl stimulation were indicated 
(mean ± s.e.m., 89 and 365 mitochondria, respectively). 
(e) Representative images of HeLa cells expressing mitochondria-localized GEM-GECO1 
(GEM-GECO1mt, upper) co-stained with JC-1 (Cayman Chemical, UK), an indicator of 
mitochondrial membrane potential (lower). The regions within the white boxes were 
expanded (right). 
(f) Time courses of GEM-GECO1mt (upper) and JC-1 (lower) upon histamine (10 μM) 
stimulation within the two regions of interest indicated in e. 
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(g) Summary of JC-1 ratio in the mitochondria responding with (mean ± s.d., 69 
mitochondria) or without (327 mitochondria) an increase in Ca
2+
 concentration upon 
histamine stimulation. The values within 6-s time window before (gray, Resting) and after 
(black, +His) histamine application were analyzed. 
CEPIA library generated in the present study. The properties of CEPIA variants that were used in the 
intraorganellar Ca2+ imaging are highlighted (magenta). cDNAs were confirmed by sequencing.
*Ca2+ titration curves were obtained by ﬁtting with a double Hill plot equation.
a. cfGCaMP2 variants
Original (CEPIA2mt) 5.1 2.5 0.67
E11K 2.1 3.6 1.4
E84R/E87K 3.3 2.8 1.2
E11K/E84R/E87K (D1ER) 2.6 0.9 14.5
E31A 1.9 0.8 15.2
E31Q (YC4er) 2.5 0.5 64.9
E31D (split-YC7.3er, CEPIA3mt) 5.0 1.5 14.5
E31D/L36M 4.0 1.1 22.4
E67D 4.7 1.4 9.2
E104D 3.8 4.2 0.99
E104Q (YC3er) 3.4 3.7 1.2
E140D 4.4 3.7 2.1
F92W 4.5 3.3 0.90
D133E 4.3 4.7 2.1
E31Q/D133E 2.2 0.6 109
E31D/D133E 5.0 2.2 33.2
E67D/D133E 5.0 2.4 31.1
E31D/E67D 2.6 1.3 470
E31D/L36M/E67D 2.8 1.2 873
E31D/E104D 4.1 1.5 20.7
E31D/L36M/E104D 4.0 1.5 25.0
E31D/L36M/E104Q 3.8 1.5 45.2
E31D/E140D 4.7 2.0 23.5
E31D/L36M/E140D 4.9 2.0 26.1
E67D/E104D 4.3 1.5 17.9
E67D/E104Q 4.2 1.4 43.7
E67D/E140D 4.7 2.1 23.9
F92W/D133E 4.6 3.0 10.3
E104D/D133E 3.5 1.2 43.8
E104D/E140D 4.2 1.2 24.4
E104Q/E140D 3.1 0.8 23.8
D133E/E140D 4.5 2.2 8.2
E67D/D133E/E140D 4.4 1.9 93.4
E104D/D133E/E140D* 1.3, 3.1 1.7, 1.3 4.8, 661
4.9 1.7 90.2
E31D/D133E/E140D 4.7 1.8 92.2
E31D/E104D/D133E 4.2 2.0 201
E31Q/F92W/D133E 2.1 0.3 1,730
E67D/F92W/D133E 4.9 2.3 75.2
E67D/E104D/D133E 4.1 2.2 154
F92W/E104D/D133E 3.5 1.3 130
F92W/E104Q/D133E* 1.5, 1.4 2.0, 0.9 4.3, 6,100
F92W/D133E/E140D 4.5 0.9 67.4
F92W/E104D/D133E/E140D* 1.3,2.7 1.9, 1.4 3.7, 1,540
E31D/F92W/E104Q/D133E 1.8 0.6 13,400
E31D/F92W/E104D/D133E (CEPIA1er) 4.2 1.3 368
E31D/F92W/D133E/E140D 3.5 1.8 411
E67D/F92W/E104Q/D133E 2.4 0.7 2,330
E67D/F92W/D104D/D133E 4.1 1.9 344
E67D/F92W/D133E/D140D 4.4 1.7 276
F92W/S101D/D133E 5.1 3.2 7.0
F92W/D95N/N97D/D133E 4.9 3.2 8.2
F92W/D95N/S101D/D133E 4.3 2.7 11.1
T26G/E31D/L36M 4.6 0.9 2.4
E31D/L36M/Q41L 3.9 1.3 15.1
E31D/L36M/K75I 3.7 1.2 9.2
E31D/L36M/Q41L/K75I 3.1 1.1 8.9
E31D/F92W/D133E 10.2 1.5 209
E31D/F92W/E104D/D133E (G-CEPIA1er) 4.7 1.9 672
E31D/E67D/F92W/E104D/D133E 3.8 0.5 3,860
E31D/D133E/E140D 24.8 1.6 147
E31D/F92W/E104D/D133E 8.1 2.1 225
E31D/F92W/D133E/E140D (GEM-CEPIA1er) 21.7 1.4 558
E31D/E104D/D133E/E140D 34.8 1.5 483
E31D/E67D/F92W/D133E/E140D 1.4 1.1 602
E31D/F92W/E104D/D133E/E140D 2.3 1.0 2,010
Hill
coeff.
Mutated amino acids
Hill
coeff.
Mutated amino acids
Hill
coeff.
Mutated amino acids
E31D/F92W/E104D/D133E 1.1 n.d. n.d.
E31D/E67D/F92W/E104D/D133E 1.2 n.d. n.d.
Original 67.5 2.6 0.31
E31D 23.7 1.2 7.2
E31D/E67D 13.0 1.2 97.1
E31D/D133E 41.3 2.4 36.4
E31D/E140D 43.6 2.2 24.2
E31D/F92W/D133E 11.2 1.9 90.0
E31D/E104D/D133E 20.8 1.7 89.7
e. GEM-GECO1 variants with original CaM
c. G-GECO1.1 variants with cfGCaMP2 CaM
d. GEM-GECO1 variants with cfGCaMP2 CaM
Dynamic
range
Kd (µM)
Hill
coeff.Mutated amino acids
E31D/F92W/D133E (CEPIA4mt)
■ Double substitutions at –Z positions
■ Substitutions at F92W and/or D133E
■ Single substitution at –Z position
■ Substitutions used in previously reported ER Ca2+ indicators
■ Triple substitutions at –Z positions
E31D/E104D/E140D 3.2 1.9 135
E67D/E104D/E140D 3.6 2.2 129
■ D133E and single substitutions at –Z positions
■ D133E and double substitutions at –Z positions
■ F92W/D133E and double substitutions at –Z positions
■ F92W/D133E and single substitutions at –Z positions
■ Other substitutions
Kd (µM)
E31D/E67D 17.6 1.2 152
E31D/F92W/D133E 21.9 2.3 16.6
E31D/E104D/D133E 19.8 2.7 26.3
E104D/D133E/E140D 12.5 1.4 50.8
E31D/E67D/F92W/D133E 17.2 1.2 211
E31D/F92W/E104D/D133E 16.9 2.3 70.9
E67D/F92W/D133E/E140D 17.6 2.1 20.0
F92W/E104D/D133E/E140D 14.9 1.0 123
E31D/E67D/F92W/E104D/D133E (R-CEPIA1er) 8.8 1.7 565
Hill
coeff.
Mutated amino acids
b. R-GECO1 variants with cfGCaMP2 CaM
Kd (µM)
Kd (µM)
Kd (µM)
Dynamic
range
Dynamic
range
Dynamic
range
Dynamic
range
Table 1. CEPIA library.
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Table 2. Properties of CEPIA variants.
*λABS, λEx, λEm are the maximum wavelength of absorption, fluorescence excitation and fluorescence emission 
spectra, respectively.
†Brightness is the product of molar extinction coefficient (ε) and quantum yield (Φ). 
‡pKa is determined as the pH at half-maximal fluorescence intensity calculated by fitting each plots to Hill 
equations. As for R-CEPIA1er, GEM-GECO1 and GEM-CEPIA1er, pKa is calculated by a double Hill equation 
(See Materials and Methods).
§Dynamic range indicates the ratio of the maximum to minimum fluorescence intensity (Fmax/Fmin) or 
fluorescence ratio (Rmax/Rmin) (See Materials and Methods).
||Mean ± s.e.m.
35 (401), 2 (500) 499 0.20 (514) 0.4 8.8
+ 24 (397), 26 (497) 498 0.46 (513) 10.5 7.4
– 36 (402), 3 (498) 499 0.19 (512) 0.5 8.7
+ 33 (401), 10 (497) 498 0.40 (511) 3.4 8.0
27 (445), 7 (576) 565 0.06 (594) 0.4 8.9
+ 58 (562) 560 0.20 (584) 11.6 6.4
25 (445), 5 (576) 570 0.09 (593) 0.5 8.9
+ 15 (448), 35 (562) 561 0.18 (584) 6.2 6.5, 9.0
34 (395) 387, 395 0.31 (510) 10.7 6.1
+ 35 (391) 387, 390 0.18 (462) 6.2 6.1, 10.1
36 (401) 381, 395 0.26 (510) 9.4 6.1
+ 36 (391) 381, 394 0.21 (462) 7.6 6.5, 10.6
G-CEPIA1er
R-CEPIA1er
GEM-CEPIA1er
GEM-GECO1 67.5 ± 10.9 306 ± 0.4 nM 2.55 ± 0.02
G-GECO1.1 14.7 ± 1.6 363 ± 4 nM 3.38 ± 0.10
R-GECO1 15.6 ± 4.1 142 ± 17 nM 2.05 ± 0.12
Probe Ca2+ ε  (mM–1 cm–1) (λABS
*) Φ (λEm
*) Brightness
†
(mM–1 cm–1)
pKa
‡ Dynamic
range§
Kd for Ca
2+ Hill
coefficient
λEx
*
558 ± 14 µM
565 ± 58 µM
4.7 ± 0.3|| 672 ± 23 µM||
8.8 ± 0.7
21.7 ± 0.6
1.95 ± 0.07||
1.70 ± 0.04
1.37 ± 0.01
–
–
–
–
–
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The primers and oligonucleotides used in the present study are listed. For the primers used for site-directed 
mutagenesis, the target mutation sites are indicated in parentheses.
Primer number Sequence
1 ATAAGCATATGCAGGTCCAACTGCAGGGAT
2 ATTAGATCTCTACAGCTCGTCCTTCTCGCT
3 AGAGGATCCATGGTCGACTCTTCACGTCGT
4 TAGCGGCCGCCTTCGCTGTCATCATTTGTA
5 GAGACCAACTGACTGAAGAGCAGATCGCAG
6 GAGTAGCCTCCCAGCCCATGGTCTTCTTCT
7 GCAACACTCGAGACCAACTGACTGAAGAGC
8 (E11K) GCTGACTGAAGAGCAGATCGCAAAATTTAA
9 (E11K) TGGTCACGCGTGTTGTACTCCAGCTT
10 (E31D) GGGCAGAACCCCACAGAAGCAGAGCTCCAG
11 (E31D) CAGAGACCGCAGCACCGTCCCCAGATCCTT
12 (E31D) CAGAGACCGCATCACCGTCCCCAGATCCTT
13 (E31Q) CTGGGGACGGTGCTGCGGTCTCT
14 (E31Q) CTGCTTGGTTGTTATTGTCCCATCCCCGTC
15 (E67D) GACAATGATGGCAAGAAAAATGAAAGACAC
16 (E67D) GACGATGATGGCAAGAAAAATGAATGACAC
17 (E67D) GACAATGATGGCACCTAAAATGCAGGACAC
18 (E67D) AGGAAATCAGGGAAGTCGATTGTGCCATTA
19 (E67D) AGGAAATCAGGGAAGTCGAAGGTACCGTCA
20 (E67D) AGGAAATCAGGGAAGTCGATGGTACCGTCA
21 (E84R/E87K) AATTCGAAAAGCGTTCCGTGTGTTTGATAA
22 (E84R/E87K) CTTTCTTCACTGTCTGTGTCTTTCATTTTT
23 (F92W) GGGATAAGGATGGCAATGGCTACATCAGT
24 (F92W) ACACACGGAACGCTTCGCGAATTTCTTCT
25 (F92W) GGGATAAGGATGGCAATGGCTACATCGGC
26 (E104D) AGCAGACCTTCGCCACGTGATGACAAACCT
27 (E104D) AGCAGATCTTCGCCACGTGATGACAAACCT
28 (E104D) AGCAGATCTTCGCCACGTGATGACAGACCT
29 (E104D) GCGCCGATGTAGCCATTGCCGTCCTTATC
30 (E104Q) GCAGAGATGTAGCCATTGCCATCCTTATC
31 (E104Q) AGCACAGCTTCGCCACGTGATGACAAACCT
32 (D133E) ATCGATGGAGAAGGTCAGGTAAACTACGAA
33 (D133E) ATCTGCTTCCCTGATCATTTCATCAACCTC
34 (D133E) GTCTGCTACCCTGATCATTTCATCAACCTC
35 (E140D) ATGATGACAGCGAAGGCGGCCGCAGAACAA
36 (E140D) TTGTACAAAGTCTTCGTAGTTTACCTGACC
37 AGGGATCCATGCGGGGTTCTCATCATCATC
38 GGGATCCATCATCATCATCG
39 TCGACGATGATGATGATGGATCCCTGCA
40 CGCGCCAAAATTCATTCACTGGGGGACCCC
41 ATGAGCGTGCTCACCCCACTCCTGCTGCGGGGGCTGACCG
42 GCAGCGCTAGGCGGCTGCCAGTCCCGCGG
43 GCCAAGATCCACAGTCTCGGCGATCCCG
44 TCATGGGGTCCCCCAGTGAATGAATTTTGG
45 CTGCCGGTCAGCCCCCGCAGCAGGAGTGGGGTGAGCACGC
46 TGGCCCGCGGGACTGGCAGCCGCCTAGCG
47 GATCCGGGATCGCCGAGACTGTGGATCT
48 ATAAGCTTGCCACCATGGGATGGAGCTGTA
49 AGAACTAGTCTACAGCTCGTCCTTCTCGCT
50 GATCCATGCTGCTGCCCGTCCCCCTGCTGC
51 TGGGCCTGCTGGGCGCCGCCGCCGACATGG 
52 CCCAGCAGCAGGGGGACGGGCAGCAGCATG
53 TCGACCATGTCGGCGGCGGCGCCCAGCAGG
54
55
56 AAGCCGCGGACATGGTGAGCAAGGGCGAGG
57 GCCGAATTCTTACAGCTCGTCCTTCTTGTACAGCTCGTCCATGC
58 CCGGGCGAATTCGGCAGATATCCATCACAC
59 GATGATGATGGGATCCTCTCATGTCCGCGG
AAACCGCGGACATGGTGAGCAAGGGCGAGG
GACGAATTCTTACAGCTCGTCCTTCTTGTACAGCTCGTCCATGC
64 ATATCTAGAGCCACCATGGATGTGTGCGCC
65 CGCCTCTAGACTACTTCTTAAGAGGCTTCT
60 CTCGGATCCATGGTGAGCAAGGGCGAGGAG
66 CTTGTACAGCTCGTCCATGCCGCCGGTGGA
61 TTAATGCGGCCGCGCCGAGAGTGATCCCGG
62 TGTCTGCAGGCTACAACAGCGACAACGTCT
63 TTGCCTGATCGCGCAAAGAGTGACCATCTT
Table 3. The list of primers and oligonucleotides.
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Figure 3
Substitutions at –Z positions Derived from cfGCaMP2 Derived from GECOsF92W/D133E substitutions
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
GCaMP2 D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
cfGCaMP2 D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
CEPIA1er D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
G-GECO1.1 D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
G-CEPIA1er D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
R-GECO1 D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
R-CEPIA1er D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
GEM-GECO1 D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
GEM-CEPIA1er D Q L T E E Q I A E F K E A F S L F D K D G D G T I T T K
31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
GCaMP2 E L G T V M R S L G Q N P T E A E L Q D M I N E V D A D G N
cfGCaMP2 E L G T V L R S L G Q N P T E A E L Q D M I N E V D A D G N
CEPIA1er D L G T V L R S L G Q N P T E A E L Q D M I N E V D A D G N
G-GECO1.1 E L G T V M R S L G Q N P T E A E L Q D M I N E V D A D G D
G-CEPIA1er D L G T V L R S L G Q N P T E A E L Q D M I N E V D A D G N
R-GECO1 E L G T V M R S L G Q N P T E A E L Q D M I N E V D A D G D
R-CEPIA1er D L G T V L R S L G Q N P T E A E L Q D M I N E V D A D G N
GEM-GECO1 E L G T V M R S L G Q N P T E A E L Q D M I N E V D A D G D
GEM-CEPIA1er D L G T V M R S L G Q N P T E A E L Q D M I N E V D A D G D
61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90
GCaMP2 G T I D F P E F L T M M A R K M K D T D S E E E I R E A F R
cfGCaMP2 G T I D F P E F L T M M A R K M K D T D S E E E I R E A F R
CEPIA1er G T I D F P E F L T M M A R K M K D T D S E E E I R E A F R
G-GECO1.1 G T I D F P E F L T M M A R K M N D T D S E E E I R E A F R
G-CEPIA1er G T I D F P E F L T M M A R K M K D T D S E E E I R E A F R
R-GECO1 G T F D F P E F L T M M A R K M N D T D S E E E I R E A F R
R-CEPIA1er G T I D F P D F L T M M A R K M K D T D S E E E I R E A F R
GEM-GECO1 G T I D F P E F L T M M A P K M Q D T D S E E E I R E A F R
GEM-CEPIA1er G T I D F P E F L T M M A P K M Q D T D S E E E I R E A F R
91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
GCaMP2 V F D K D G N G Y I S A A E L R H V M T N L G E K L T D E E
cfGCaMP2 V F D K D G N G Y I S A A E L R H V M T N L G E K L T D E E
CEPIA1er V W D K D G N G Y I S A A D L R H V M T N L G E K L T D E E
G-GECO1.1 V F D K D G N G Y I G A A E L R H V M T N L G E K L T D E E
G-CEPIA1er V W D K D G N G Y I S A A D L R H V M T N L G E K L T D E E
R-GECO1 V F D K D G N G Y I G A A E L R H V M T D L G E K L T D E E
R-CEPIA1er V W D K D G N G Y I S A A D L R H V M T N L G E K L T D E E
GEM-GECO1 V F D K D G N G Y I G A A E L R H V M T N L G E K L T D E E
GEM-CEPIA1er V W D K D G N G Y I G A A E L R H V M T N L G E K L T D E E
121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148
GCaMP2 V D E M I R E A D I D G D G Q V N Y E E F V Q M M T A K
cfGCaMP2 V D E M I R E A D I D G D G Q V N Y E E F V Q M M T A K
CEPIA1er V D E M I R E A D I D G E G Q V N Y E E F V Q M M T A K
G-GECO1.1 V D E M I R V A D I D G D G Q V N Y E E F V Q M M T A K
G-CEPIA1er V D E M I R E A D I D G E G Q V N Y E E F V Q M M T A K
R-GECO1 V D E M I R V A D I D G D G Q V N Y E E F V Q M M T A K
R-CEPIA1er V D E M I R E A D I D G E G Q V N Y E E F V Q M M T A K
GEM-GECO1 V D E M I R V A D I D G D G Q V N Y E E F V Q M M T A K
GEM-CEPIA1er V D E M I R V A D I D G E G Q V N Y E D F V Q M M T A K
Ca2+ binding Loop IV
–Z
Ca2+ binding Loop III
–Y –X –Z
+X +Y +Z
Ca2+ binding Loop II
+X +Y +Z –Y –X
Ca2+ binding Loop I
–Z
+X +Y +Z –Y –X
–Z+X +Y +Z –Y –X
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Figure 6
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Figure 7
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Figure 8
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